{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:47:27Z","timestamp":1775796447741,"version":"3.50.1"},"reference-count":852,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.nefroe.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:52:13Z","timestamp":1659048733000},"page":"5-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S2","title":["Recommendations for living donor kidney transplantation"],"prefix":"10.1016","volume":"42","author":[{"given":"Miguel \u00c1ngel","family":"Frutos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda de la Oliva","family":"Valent\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Alonso-Melgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantino","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorka","family":"Garc\u00eda-Erauzkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Gonz\u00e1lez\u2013Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluis","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Guti\u00e9rrez-Dalmau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis L\u00f3pez del","family":"Moral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Musquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Revuelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos J Van-der","family":"Hofstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Alonso-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purificaci\u00f3n","family":"Bernabeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Caro-Oleas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Facundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Gil-Vernet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mahillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"P\u00e9rez-Saez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluis","family":"Peri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Dom\u00ednguez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.nefroe.2022.07.001_bib0005","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Nefrolog\u00eda \u201cSEN\u201d y de la Organizaci\u00f3n Nacional de Trasplantes \u201cONT\u201d sobre trasplante renal donante vivo","volume":"30","author":"Gu\u00edas","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0010","article-title":"Guidelines for living donor kidney","author":"UK Guidelines","year":"2018","journal-title":"Transplantation"},{"issue":"8S","key":"10.1016\/j.nefroe.2022.07.001_bib0015","article-title":"Clinical practice guideline on the evaluation and care of living kidney donors","volume":"101","author":"KDIGO","year":"2017","journal-title":"Transplantation"},{"issue":"Supl. 2","key":"10.1016\/j.nefroe.2022.07.001_bib0020","first-page":"7","article-title":"ERBP guideline on the management and evaluation of the kidney donor and recipient","volume":"2","author":"European Renal Best Practice Transplantation Guideline Development Group","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"Supl. 6","key":"10.1016\/j.nefroe.2022.07.001_bib0025","first-page":"7","article-title":"Jerarquizaci\u00f3n del conocimiento cient\u00edfico. El sistema GRADE","volume":"29","author":"Quereda","year":"2009","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/ajt.14702","article-title":"An economic assessment of contemporary kidney transplant practice","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.1956.02960390027008","article-title":"Successful homotransplantation of the human kidney between identical twins","volume":"160","author":"Merrill","year":"1956","journal-title":"J Am Med Assoc"},{"issue":"Supl. 6","key":"10.1016\/j.nefroe.2022.07.001_bib0040","first-page":"S53","article-title":"A report of the Amsterdam Forum On the Care of the Live Kidney Donor: data and medical guidelines","volume":"79","author":"Delmonico","year":"2005","journal-title":"Transplantation"},{"issue":"8S Suppl 1","key":"10.1016\/j.nefroe.2022.07.001_bib0045","first-page":"S1","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0050","series-title":"\u201cGODT\u201d, WHO-ONT Collaboration Internets","author":"Global Observatory on Donation and Transplantation","year":"2016"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/TP.0b013e31823360b1","article-title":"2009 global data in organ donation and transplantation: activities, laws, and organization","volume":"92","author":"Mahillo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200008103430611","article-title":"Nondirected donation of kidneys from living donors","volume":"343","author":"Matas","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0065","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2008.02414.x","article-title":"2202 kidney transplant recipients with 10 years of graft function: what happens next?","volume":"8","author":"Matas","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0070","series-title":"ERA-EDTA registry ERA-EDTA","author":"Annual report","year":"2020"},{"issue":"Suppl 2","key":"10.1016\/j.nefroe.2022.07.001_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajt.15274","article-title":"OPTN\/SRTR 2017 annual data report: kidney","volume":"19","author":"Hart","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003337","article-title":"A propensity score-weighted comparison of outcomes between living and standard criteria deceased donor kidney transplant recipients","author":"Yohanna","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0085","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0090","first-page":"159","article-title":"Why renal transplant from living donors gives better results than cadaver renal transplant?","volume":"28","author":"Guirado","year":"2008","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/tri.12217","article-title":"Factors influencing long-term outcome after kidney transplantation","volume":"27","author":"Legendre","year":"2014","journal-title":"Transplant International"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0100","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1523-1755.2000.00287.x","article-title":"Effect of waiting time on renal transplant outcome","volume":"58","author":"Meier-Kriesche","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0105","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1111\/j.1600-6143.2012.04138.x","article-title":"Continuously evaluating performance in deceased donation: the Spanish quality assurance program","volume":"12","author":"de la Rosa","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0110","unstructured":"Documento de consenso nacional sobre Donaci\u00f3n en Asistolia consultado Mayo 2020. Available from: http:\/\/www.ont.es\/infesp\/DocumentosDeConsenso\/DONACI%C3%93N%20EN%20ASISTOLIA%20EN%20ESPA%C3%91A.%20SITUACI%C3%93N%20ACTUAL%20Y%20RECOMENDACIONES.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0115","doi-asserted-by":"crossref","first-page":"pS381","DOI":"10.1097\/01.tp.0000543138.87856.a4","article-title":"Spanish non standard risk donor project \u201cPeriod 2013-June 2017\u201d","volume":"102","author":"Mahillo","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0120","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/ajt.14104","article-title":"How Spain reached 40 deceased organ donors per million population","volume":"17","author":"Matesanz","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0125","unstructured":"Documento de Consenso del Grupo de Estudio de la Infecci\u00f3n en el Trasplante \u201cGESITRA\u201d perteneciente a la Sociedad de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica \u201cSEIMC\u201d y la Organizaci\u00f3n Nacional de Trasplantes \u201cONT\u201d sobre los Criterios de Selecci\u00f3n del Donante de \u00d3rganos S\u00f3lidos en relaci\u00f3n a las Enfermedades Infecciosas Organizaci\u00f3n Nacional de Trasplantes 2019 consultado Mayo 2020. Available from: http:\/\/www.ont.es\/infesp\/Paginas\/DocumentosdeConsenso.aspx"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0130","unstructured":"Documento de Consenso sobre la Evaluaci\u00f3n del Donante de \u00d3rganos para prevenir la Transmisi\u00f3n de Enfermedades Neopl\u00e1sicas. Internet. Organizaci\u00f3n Nacional de Trasplantes consultado mayo de 2020. Available from: http:\/\/www.ont.es\/infesp\/Paginas\/DocumentosdeConsenso.aspx."},{"key":"10.1016\/j.nefroe.2022.07.001_bib0135","series-title":"Guide to the quality and safety of organs for transplantation","author":"Council of Europe","year":"2018"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0140","unstructured":"Documento de Consenso para la valoraci\u00f3n de donantes con serolog\u00eda positiva para el virus de la hepatitis C Organizaci\u00f3n Nacional de Trasplantes. cosultado Mayo 2020. Disponible en: http:\/\/www.ont.es\/infesp\/Paginas\/DocumentosdeConsenso.aspx"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0145","series-title":"Memorias de actividad de donaci\u00f3n y trasplante renal","author":"Memorias de actividad de donaci\u00f3n y trasplante renal","year":"2019"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0150","unstructured":"Informe de Di\u00e1lisis y Trasplante. Registro Espa\u00f1ol de Enfermos Renales. XLIX Congreso de la SEN A Coru\u00f1a REER 2019. consultado Julio 2020. Available from: https:\/\/www.senefro.org\/contents\/webstructure\/SEN_2019_REER_modificada.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003242","article-title":"Living kidney donor evaluation","author":"Claisse","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2010.04.003","article-title":"Laparoscopic living-donor nephrectomy: analysis of the existing literature","volume":"58","author":"Greco","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa0804883","article-title":"Long-term consequences of kidney donation","volume":"360","author":"Ibrahim","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0170","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/ajt.15179","article-title":"Long-term psychosocial outcomes after nondirected donation: a single-center experience","volume":"19","author":"Jacobs","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0180","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1097\/TXD.0000000000000913","article-title":"Postdonation eGFR and new-onset antihypertensive medication use after living kidney donation","volume":"5","author":"Lentine","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","author":"Mjoen","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/TP.0b013e3181ec29f0","article-title":"WHO guiding principles on human cell, tissue and organ transplantation","volume":"90","author":"World Health Organization","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0195","unstructured":"The Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention of human rights and biomedicine, Council of Europe website. Internet., consultado Abril 2020. Available from: http:\/\/conventions.coe.int\/treaty\/EN\/Treaties\/Html\/164.htm"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0200","unstructured":"WHO, Additional Protocol to the Convention on Human Rights and Biomedicine concerning Transplantation of Organs and Tissues of Human Origin, consultado Abril 2020. Available from: https:\/\/rm.coe.int\/1680081562"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0205","unstructured":"Real Decreto 1723\/2012, de 28 de diciembre, por el que se regulan las actividades de obtenci\u00f3n, utilizaci\u00f3n cl\u00ednica y coordinaci\u00f3n territorial de los \u00f3rganos humanos destinados al trasplante y se establecen requisitos de calidad y seguridad, Bolet\u00edn Oficial del Estado \u201cBOE\u201d, 313, 2012 Dic, 89315"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0210","unstructured":"Directiva 2010\/53\/UE del Parlamento Europeo y del Consejo de 7 de julio de 2010 sobre normas de calidad y seguridad de los \u00f3rganos humanos destinados al trasplante, Diario Oficial de la Uni\u00f3n Europea, 207, 2010 August, 14"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1432-2277.2010.01204.x","article-title":"Spanish experience as a leading country: what kind of measures were taken?","volume":"24","author":"Matesanz","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0220","first-page":"379","article-title":"No indicar el trasplante de vivo es una mala pr\u00e1ctica","volume":"29","author":"Valent\u00edn","year":"2020","journal-title":"Nefrolog\u00eda"},{"issue":"Suppl 2","key":"10.1016\/j.nefroe.2022.07.001_bib0225","first-page":"57","article-title":"Opinion survey on renal donation from living donor","volume":"25","author":"Alvarez","year":"2005","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0230","doi-asserted-by":"crossref","first-page":"e13657","DOI":"10.1111\/ctr.13657","article-title":"Kidney donor outcomes \u226550 years after donation","volume":"33","author":"Keys","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ndt\/gfw429","article-title":"Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES Working Group","volume":"32","author":"Maggiore","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0240","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/01.tp.0000542751.82168.ad","article-title":"Living kidney donation in Spain a global strategy to increase this modality of transplantation","volume":"102","author":"Valent\u00edn","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0245","author":"International figures on donation and transplantation","year":"2018","journal-title":"Newslwetter Transplant Internet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM199508103330601","article-title":"High survival rates of kidney transplants from spousal and living unrelated donors","volume":"333","author":"Terasaki","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0255","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/TP.0000000000002432","article-title":"Building kidney exchange programmes in Europe\u2014an overview of exchange practice and activities","volume":"103","author":"Bir\u00f3","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0260","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.nefro.2019.02.010","article-title":"ABO-incompatible living-donor kidney transplantation: study of 48 patients after desensitisation","volume":"39","author":"Fern\u00e1ndez Rivera","year":"2019","journal-title":"Nefrologia"},{"issue":"10185","key":"10.1016\/j.nefroe.2022.07.001_bib0265","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis","volume":"393","author":"Scurt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0270","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12026-009-8157-y","article-title":"Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange","volume":"47","author":"Warren","year":"2010","journal-title":"Immunologic Research"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0280","first-page":"287","article-title":"Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program","author":"de Klerk","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0285","unstructured":"Registro espa\u00f1ol de donante vivo renal. Memoria de resultados 2010-2017, Organizaci\u00f3n Nacional de Trasplantes. Internet., consultado Junio 2020. Available from: http:\/\/www.ont.es\/infesp\/Registros\/MEMORIA%20REGISTRO%20ESPA%C3%91OL%20DONANTE%20VIVO%202010-2017.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0290","unstructured":"Plan Estrat\u00e9gico en Donaci\u00f3n y Trasplante de \u00d3rganos 2018-2022, consultado Junio 2020. Available from: http:\/\/www.ont.es\/infesp\/Documents\/PLAN%20ESTRAT%C3%89GICO%20DONACI%C3%93N%20Y%20TRASPLANTE%20DE%20%C3%93RGANOS%202018-2022.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0295","unstructured":"Toolbox Living Kidney Donation. Developed by the working group on living donation, European Union., 2014, consultado 26 Noviembre 2019\u201d. Available from: https:\/\/ec.europa.eu\/health\/\/sites\/health\/files\/blood_tissues_organs\/docs\/eutoolbox_living_kidney_donation_en.pdf"},{"issue":"Suppl 2","key":"10.1016\/j.nefroe.2022.07.001_bib0300","first-page":"14","article-title":"Aspectos \u00e9ticos de la donaci\u00f3n renal de vivo","volume":"30","author":"Casares","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0305","series-title":"Fundamentos de Bio\u00e9tica, 3\u00aa ed","first-page":"978","author":"Gracia","year":"2008"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0310","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMp058155","article-title":"The ethics of organ donation by living donors","volume":"353","author":"Truog","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0315","series-title":"Nuffield Council on Bioethics","author":"Human bodies: donation for medicine and research","year":"2011"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0320","series-title":"Convention on Human Rights and Biomedicine","author":"Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine","year":"1997"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4321\/S1135-76062015000100007","article-title":"\u00c9tica en donaci\u00f3n y trasplante de \u00f3rganos: una alianza rentable","volume":"21","author":"Frutos","year":"2015","journal-title":"Cuad Med Forense"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0330","unstructured":"Principios rectores de la Organizaci\u00f3n Mundial de la Salud sobre trasplante de c\u00e9lulas, tejidos y \u00f3rganos humanos, WHO., consultado 31 Enero 2020. Available from: http:\/\/www.who.int\/transplantation\/Guiding_PrinciplesTransplantation_WHA63.22sp.pdf?ua=1"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0335","unstructured":"Ethical Guidelines for the Evaluation of Living Organ Donors, UHN., consultado 7 Enero 2020. Available from: https:\/\/www.uhn.ca\/Transplant\/About\/Documents\/MOT_TransplantBioethics_EthicalGuidelines.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0340","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/ajkd.2000.9794","article-title":"Gender disparity in living renal transplant donation","volume":"36","author":"Zimmerman","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0345","unstructured":"Trasplante renal donante vivo. Memoria de resultados Espa\u00f1a 2010-2017, ONT., consultado 13 Octubre 2020. Available from: http:\/\/www.ont.es\/infesp\/Registros\/Memoria_Registro_espa%C3%B1ol_donantevivo_20102017.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0350","author":"Council of Europe Convention against Trafficking in Human Organs","year":"2020","journal-title":"CETS 216"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0b013e318185ffc9","volume":"86","author":"The Declaration of Istanbul on organ trafficking and transplant tourism","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0360","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2215\/CJN.03050906","article-title":"Payment for kidneys: a government-regulated system is not ethically achievable","volume":"1","author":"Harmon","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0365","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0000000000001164","article-title":"Paid living donation and growth of deceased donor programs","volume":"100","author":"Ghahramani","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ckj\/sfz067","article-title":"Raising awareness of unspecified living kidney donation: an ELPAT view","volume":"13","author":"Burnapp","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-6143.2011.03765.x","article-title":"The ethical complexities of online organ solicitation via donor-patient websites: avoiding the \u201cbeauty contest\u201d","volume":"12","author":"Neidich","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0380","unstructured":"Additional Protocol to the Convention on Human Rights and Biomedicine concerning Transplantation of Organs and Tissues of Human Origin, consultado 31 Enero 2020. Available from: https:\/\/rm.coe.int\/1680081562"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.ajkd.2017.07.014","article-title":"Donor and recipient perspectives on anonymity in kidney donation from live donors: a multicenter survey study","volume":"71","author":"Slaats","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0390","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/TP.0b013e3181a4eae5","article-title":"Donor Nephrectomy Outcomes Research \u201cDONOR\u201d network discovering misattributed paternity in living kidney donation: prevalence, preference, and practice","volume":"87","author":"Young","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0395","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s00268-014-2549-4","article-title":"Ethical issues regarding related and nonrelated living organ donors","volume":"38","author":"Testa","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0400","series-title":"Diez razones para recomendar el trasplante renal de donante vivo","author":"Frutos","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0405","series-title":"Risk tool for kidney donor candidates","author":"ESRD","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0410","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.transproceed.2018.03.038","article-title":"Follow-up status of living kidney donors after transplantation","volume":"50","author":"Ju","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0415","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2011.03816.x","article-title":"Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations","volume":"11","author":"Leichtman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0420","unstructured":"Directiva 2010\/45\/UE del Parlamento Europeo y del Consejo sobre normas de calidad y seguridad de los \u00f3rganos humanos destinados al trasplante, consultado 13 Octubre 2020. Available from: http:\/\/www.ont.es\/infesp\/Legislacin\/Directiva 2010-45-EU.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0425","unstructured":"Resolution CM\/Res\u201c2017\u201d1 on principles for the selection, evaluation, donation and follow-up of the non-resident living organ donors, consultado 3 Febrero 2020. Available from: https:\/\/www.edqm.eu\/sites\/default\/files\/cmres_2017_1-on_principles_for_selection_eval_donation_and_follow_up_of_nrld.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0430","unstructured":"Modificaci\u00f3n RD 1030\/2006, BOE., consultado 13 Octubre 2020. Available from: https:\/\/www.boe.es\/boe\/dias\/2011\/03\/17\/pdfs\/BOE-A-2011-4884.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0435","unstructured":"Trasplante renal donante vivo en receptores no residentes en Espa\u00f1a. Protocolo de actuaci\u00f3n, ONT., 2014 Oct, Documento no publicado. Favor de aportar m\u00e1s informaci\u00f3n en la referencia 87"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0440","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ajt.13001","article-title":"The independent living donor advocate: a guidance document from the American Society of Transplantation's Living Donor Community of Practice","volume":"15","author":"Hays","year":"2015","journal-title":"Am J Transplant"},{"issue":"Supl 2","key":"10.1016\/j.nefroe.2022.07.001_bib0445","first-page":"39","article-title":"Informaci\u00f3n a pacientes: cu\u00e1ndo y qu\u00e9 informaci\u00f3n suministrar","volume":"30","author":"Frutos","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0450","author":"Perestelo-P\u00e9rez","year":"2013"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0455","unstructured":"http:\/\/ decisionscompartides.gencat.cat\/es\/decidir-sobre\/malaltia-renal-cronica-avancada\/index.html"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0460","first-page":"143","article-title":"El trasplante renal de donante vivo en Espa\u00f1a. Una gran oportunidad","volume":"28","author":"Dom\u00ednguez-Gil","year":"2008","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0465","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0470","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/TP.0000000000001019","article-title":"iChoose Kidney: a clinical decision aid for kidney transplantation versus dialysis treatment","volume":"100","author":"Patzer","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0475","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/ajt.14693","article-title":"Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: a randomized controlled trial","volume":"18","author":"Patzer","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0480","doi-asserted-by":"crossref","DOI":"10.1177\/2054358118799693","article-title":"Predicting 3-year survival in patients receiving maintenance dialysis: an external validation of iChoose Kidney in Ontario, Canada","volume":"5","author":"Tan","year":"2018","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40472-017-0133-1","article-title":"Decision aids to increase living donor kidney transplantation","volume":"4","author":"Gander","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0490","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/ajt.13173","article-title":"Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care","volume":"15","author":"LaPointe Rudow","year":"2015","journal-title":"Am J Transplant"},{"issue":"Supl. 3","key":"10.1016\/j.nefroe.2022.07.001_bib0495","first-page":"123","article-title":"Trasplante renal anticipado","volume":"28","author":"Morales","year":"2008","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0500","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1001\/jama.284.22.2919","article-title":"Consensus statement on the live organ donor","volume":"284","author":"Abecassis","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0505","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0510","unstructured":"Living Donor Informed Consent Checklist consultado 12 Junio 2020. Available from: https:\/\/optn.transplant.hrsa.gov\/resources\/living-donation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0515","unstructured":"Plain language informed consent policy summary \u201cEnglish and Spanish\u201d, consultado 12 Junio 2020. Available from: https:\/\/optn.transplant.hrsa.gov\/resources\/living-donation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0520","series-title":"Enhancing living donation: a Canadian forum-report and recommendations, February 9-12, 2006, Vancouver, British Columbia","author":"Canadian Council for Donation and Transplantation","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0525","unstructured":"Organ and tissue donation by living donors. Guidelines for ethical practice for health professionals, NHMRC., 2007, consultado 12 Junio 2020. Available from: https:\/\/www.nhmrc.gov.au\/guidelines-publications\/e75"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0530","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2215\/CJN.01030115","article-title":"Living donor kidney transplantation: facilitating education about live kidney donation-recommendations from a consensus conference","volume":"10","author":"Tan","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0535","unstructured":"OPTN Policies, Policy 14: Living Donation, OPTN \/UNOS., cosultado 12 Junio 2020. Available from: https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/oxfordjournals.ndt.a027990","article-title":"Section II: evaluation and selection of donors","volume":"15","author":"European Best Practice Guidelines for Renal Transplantation","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0545","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12882-018-0935-0","article-title":"Interviews of living kidney donors to assess donation-related concerns and information-gathering practices","volume":"19","author":"Ruck","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0550","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2215\/CJN.13441217","article-title":"Identifying outcomes that are important to living kidney donors. A nominal group technique study","volume":"13","author":"Hanson","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0555","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1600-6143.2012.04070.x","article-title":"Single-center kidney paired donation: the Methodist San Antonio experience","volume":"12","author":"Bingaman","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0560","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0b013e31827e31f7","article-title":"Anonymity and live-donor transplantation: an ELPAT view","volume":"95","author":"Mamode","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0565","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/ajt.13218","article-title":"Equipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs","volume":"15","author":"Cuffy","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0570","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1525-139X.2002.00541.x","article-title":"Disclosure of misattributed paternity: issues involved in the discovery of unsought information","volume":"15","author":"Wright","year":"2002","journal-title":"Semin Dial"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0575","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1600-6143.2009.03011.x","article-title":"Good ethics requires good science: why transplant programs should not disclose misattributed parentage","volume":"10","author":"Ross","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0580","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MOT.0b013e328327b21f","article-title":"The dilemma of unintentional discovery of misattributed paternity in living kidney donors and recipients","volume":"14","author":"Schroder","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0585","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ctr.12651","article-title":"To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors","volume":"29","author":"Meadow","year":"2015","journal-title":"J Clin Trans Res"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0590","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1038-5282.2001.00400.x-i1","article-title":"Morbidity and mortality after living kidney donation, 1999\u20132001: survey of United States transplant centers","volume":"3","author":"Matas","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0595","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2007.01975.x","article-title":"2509 living donor nephrectomies, morbidity and mortality, including the UK introduction of laparoscopic donor surgery","volume":"7","author":"Hadjianastassiou","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0600","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2010.237","article-title":"Perioperative mortality and longterm survival following live kidney donation","volume":"303","author":"Segev","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0605","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMc090444","article-title":"Long-term consequences of kidney donation","volume":"360","author":"Dols","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0610","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-145-3-200608010-00006","article-title":"Meta-analysis: risk for hypertension in living kidney donors","volume":"145","author":"Boudville","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0615","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1408932","article-title":"Donor Nephrectomy Outcomes Research \u201cDONOR\u201d network gestational hypertension and preeclampsia in living kidney donors","volume":"372","author":"Garg","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0620","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2009.02548.x","article-title":"Pregnancy outcomes after kidney donation","volume":"9","author":"Ibrahim","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0625","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0630","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/TP.0000000000000920","article-title":"Outcomes of live kidney donors who develop end-stage renal disease","volume":"100","author":"Muzaale","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0635","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1681\/ASN.2014030302","article-title":"Kidney transplant outcomes for prior living organ donors","volume":"26","author":"Potluri","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0640","first-page":"485","article-title":"The psychosocial meanings of living related kidney organ donation: recipient and donor perspectives-literature review","volume":"26","author":"Conrad","year":"1999","journal-title":"ANNA J"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0645","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.02280215","article-title":"Disclosing health and health behavior information between living donors and their recipients","volume":"10","author":"Mataya","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0650","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2215\/CJN.06130809","article-title":"Attitudes to sharing personal health information in living kidney donation","volume":"5","author":"Hizo-Abes","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0655","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2215\/CJN.02180606","article-title":"Creating a medical, ethical, and legal framework for complex living kidney donors","volume":"1","author":"Reese","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0660","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1600-6143.2009.03010.x","article-title":"What the medical excuse teaches us about the potential living donor as patient","volume":"10","author":"Ross","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0665","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/medethics-2014-102184","article-title":"Opting out: confidentiality and availability of an \u2018alibi\u2019 for potential living kidney donors in the USA","volume":"41","author":"Thiessen","year":"2015","journal-title":"J Med Ethics"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0670","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2215\/CJN.00950115","article-title":"Living donor kidney transplantation: improving education outside of transplant centers about live donor transplantation\u2014recommendations from a consensus conference","volume":"10","author":"Waterman","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0675","series-title":"Prensa, donaci\u00f3n y trasplantes. Manejo de las situaciones de crisis, Matesanz R. El modelo espa\u00f1ol de coordinaci\u00f3n y trasplantes, 2\u00aa ed., Aula M\u00e9dica","first-page":"215","author":"Matesanz","year":"2015"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0680","series-title":"Grupo de Opini\u00f3n del Observatori de Bio\u00e8tica i Dret Parc Cient\u00edfic de Barcelona, Documento sobre trasplante de \u00f3rganos a partir de donante vivo","author":"Buisan","year":"2011"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0685","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1097\/TP.0000000000002253","article-title":"British Transplantation Society\/Renal Association UK Guidelines for living donor kidney transplantation 2018: summary of updated guidance","volume":"102","author":"Andrews","year":"2018","journal-title":"Transplantation"},{"issue":"Supl. 2","key":"10.1016\/j.nefroe.2022.07.001_bib0690","first-page":"47","article-title":"Assessment and selection of kidney living donors","volume":"30","author":"Gentil Govantes","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0695","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TP.0b013e31817ba9e3","article-title":"Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada","volume":"86","author":"Garg","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0700","first-page":"320","article-title":"The influence of dietary protein intake on specific renal functions in normal man","volume":"44","author":"Pullman","year":"1954","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0705","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/TP.0b013e318176aefc","article-title":"Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors","volume":"86","author":"Issa","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0710","first-page":"143","article-title":"New methods for estimating glomerular filtration rate. Achieving more precision in diagnosing chronic kidney disease","volume":"30","author":"Alcazar","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0715","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ajt.13540","article-title":"Estimated GFR for living kidney donor evaluation","volume":"16","author":"Huang","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0720","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/ajt.13908","article-title":"Estimated or measured GFR in living kidney donors work-up?","volume":"16","author":"Gaillard","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0725","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: a survey of US transplant centers","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0730","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.tp.0000181098.56617.b2","article-title":"Persistent, asymptomatic, microscopic hematuria in prospective kidney donors","volume":"80","author":"Koushik","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0735","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","article-title":"A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases","volume":"94","author":"Bullich","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0740","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1600-6143.2010.03077.x","article-title":"Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy","volume":"10","author":"Kido","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0745","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI26662","article-title":"Kidney stone disease","volume":"115","author":"Coe","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0750","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0755","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/TP.0b013e3182875e00","article-title":"Kidneys from donors with incidental renal tumors: should they be considered acceptable option for transplantation?","volume":"95","author":"Musquera","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0760","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1464-410X.2009.08681.x","article-title":"Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy","volume":"104","author":"Sener","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0765","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0770","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ajt.13970","article-title":"Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy","volume":"17","author":"Thomas","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0775","volume":"10","author":"Len","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Supl. 4","key":"10.1016\/j.nefroe.2022.07.001_bib0780","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1600-6143.2009.02888.x","article-title":"Screening of donor and recipient prior to solid organ transplantation","volume":"9","author":"Fischer","year":"2009","journal-title":"Am J Transplant"},{"issue":"Supl. 7","key":"10.1016\/j.nefroe.2022.07.001_bib0785","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1469-0691.12557","article-title":"Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections","volume":"20","author":"Len","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0790","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/ajt.12386","article-title":"Excerpt from PHS guideline for reducing HIV HBV and HCV transmission through organ transplantation","volume":"13","author":"Seem","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0795","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/ajt.15582","article-title":"Lessons from the real world: HCV-infected donor kidney transplantation as standard practice","volume":"19","author":"Durand","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0800","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0805","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1681\/ASN.2017080853","article-title":"HIV-positive kidney donor selection for HIV-positive transplant recipients","volume":"29","author":"Muller","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0810","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/14787210.5.2.295","article-title":"Prevention and management of cytomegalovirus infection in solid-organ transplantation","volume":"5","author":"Mwintshi","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 3","key":"10.1016\/j.nefroe.2022.07.001_bib0815","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0820","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients","volume":"339","author":"Regamey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0825","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ajt.14516","article-title":"Donor-derived Kaposi's sarcoma in a liver-kidney transplant recipient","volume":"18","author":"Dollard","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0830","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.12666","article-title":"Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy","volume":"14","author":"Levi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0835","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0956462415624059","article-title":"UK national guidelines on the management of syphilis 2015","volume":"27","author":"Kingston","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0840","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.transproceed.2015.11.045","article-title":"Donor-derived strongyloidiasis infection in solid organ transplant recipients: a review and pooled analysis","volume":"48","author":"Kim","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0845","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-6143.2011.03444.x","article-title":"Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group","volume":"11","author":"Chin-Hong","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0850","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/ajt.12340","article-title":"Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001\u20132011","volume":"13","author":"Huprikar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0855","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4321\/S2254-28842019000200003","article-title":"El trasplante renal de donante vivo: una opci\u00f3n terap\u00e9utica en Enfermedad Renal Cr\u00f3nica Avanzada","volume":"22","author":"Garc\u00eda-Mart\u00ednez","year":"2019","journal-title":"Enferm Nefrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0860","unstructured":"Protocolo de donaci\u00f3n Renal Altruista en Espa\u00f1a. Organizaci\u00f3n Nacional de Trasplantes, consultado 22 Febrero 2020. Available from: http:\/\/www.ont.es\/infesp\/DocumentosDeConsenso\/Prococolo_donaci%C3%B3n_renal_altruista.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0865","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4321\/S0004-06142005000600006","article-title":"Valoraci\u00f3n de los candidatos a trasplante renal de donante vivo","volume":"58","author":"Guti\u00e9rrez-Dalmau","year":"2005","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0870","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/lt.20578","article-title":"Psychiatric and psychosocial aspects of liver transplantation","volume":"11","author":"Krahn","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0875","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1176\/appi.psy.44.6.452","article-title":"Guidelines for conducting a psychiatric evaluation of the unrelated kidney donor","volume":"44","author":"Leo","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0880","doi-asserted-by":"crossref","first-page":"139","DOI":"10.18682\/pd.v6i0.446","article-title":"Donaci\u00f3n de \u00f3rganos: una mirada psicol\u00f3gica","volume":"6","author":"Natenson","year":"2008","journal-title":"Psicodebate: Psicolog\u00eda, Cultura y Sociedad"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0885","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.TP.0000084320.57817.32","article-title":"Psychological consultation before living kidney donation: finding out and handling problem cases","volume":"27","author":"Schweitzer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.psy.46.1.1","article-title":"Live organ donation: social context, clinical encounter, and the psychology of communication","volume":"46","author":"Surman","year":"2005","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0895","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1037\/0022-006X.70.3.771","article-title":"Psychological assessment and care of organ transplant patients","volume":"70","author":"Olbrisch","year":"2002","journal-title":"J Consult Clin Psychol"},{"issue":"Supl. 4","key":"10.1016\/j.nefroe.2022.07.001_bib0900","first-page":"iv11","article-title":"Living-donor liver transplantation: evaluation of donor and recipient","volume":"19","author":"Sauer","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0905","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.ki.5002125","article-title":"Living donor kidney transplantation in a global environment","volume":"71","author":"Delmonico","year":"2007","journal-title":"Kindney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0910","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291707000979","article-title":"The psychological evaluation of Samaritan kidney donors: a systematic review","volume":"38","author":"Kranenburg","year":"2008","journal-title":"Psychol Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0915","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.rcp.2017.01.001","article-title":"La evaluaci\u00f3n psicosocial de un donante vivo de ri\u00f1\u00f3n","volume":"47","author":"Torres-Guti\u00e9rrez","year":"2018","journal-title":"Rev Colomb Psiquiatr"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0920","article-title":"Documento sobre Trasplante de \u00f3rganos de donante vivo del Grupo de Opini\u00f3n del Observatori de Bio\u00e8tica i Dret","volume":"24","author":"Buisan","year":"2012","journal-title":"Rev Bioet Derecho"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0925","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0022-3514.56.2.267","article-title":"Assessing coping strategies: a theoretically based approach","volume":"56","author":"Carver","year":"1989","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0930","first-page":"1","article-title":"Utilizaci\u00f3n de los test en Espa\u00f1a: El punto de vista de los psic\u00f3logos","volume":"41","author":"Mu\u00f1iz","year":"2020","journal-title":"Pap Psicol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0935","series-title":"MCMI-III. Millon Clinical Multiaxial Inventory-III. Manual, 4a ed","author":"Millon","year":"2011"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0940","series-title":"MCMI-IV: Millon Clinical Multiaxial Inventory Manual","author":"Millon","year":"2015"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0945","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1207\/s15327752jpa6702_1","article-title":"Comparing the diagnostic efficiency of the MMPI MCMI-II, and Rorschach: a review","volume":"67","author":"Ganellen","year":"1996","journal-title":"J Pers Assess"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0950","series-title":"A comparison of the MCMI-III and the MMPI-2 in a chronic pain population","author":"Hardie","year":"2004"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0955","doi-asserted-by":"crossref","first-page":"213","DOI":"10.25100\/cm.v44i4.1312","article-title":"Individual differences in personality profiles among potential living kidney transplant donors","volume":"44","author":"Van-der Hofstadt","year":"2013","journal-title":"Colomb M\u00e9dica"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0960","doi-asserted-by":"crossref","first-page":"e0221222","DOI":"10.1371\/journal.pone.0221222","article-title":"Personality clusters and psychopathology associated in potential live kidney donors","volume":"14","author":"Leal","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0965","first-page":"100","article-title":"Seguimiento del donante vivo a corto, medio y largo plazo","volume":"30","author":"Oppenheimer","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0970","first-page":"633","article-title":"Symptoms of anxiety and depression in different stages of organ transplant","volume":"7","author":"P\u00e9rez San Gregorio","year":"2007","journal-title":"Int J Clin Health Psychol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0975","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bjhp.12184","article-title":"Predicting mental health after living kidney donation: the importance of psychological factors","volume":"21","author":"Timmerman","year":"2016","journal-title":"Br J Health Psychol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0980","series-title":"Physiology of the human kidney","first-page":"712","author":"Wesson","year":"1969"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0985","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0990","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ckj\/sfx026","article-title":"Age-dependent reference intervals for estimated and measured glomerular filtration rate","volume":"10","author":"Pottel","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2022.07.001_bib0995","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000450893","article-title":"Glomerular filtration rate in healthy living potential kidney donors: a meta-analysis supporting the construction of the full age spectrum equation","volume":"135","author":"Pottel","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1000","unstructured":"Registro Espa\u00f1ol de Trasplante Renal con Donante Vivo \u201cRETReVi\u201d, Memoria de resultados 2010-2017, Available from: http:\/\/www.ont.es\/infesp\/Paginas\/RegistroVivoRenal.aspx"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1005","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/ndt\/gfs265","article-title":"Normal reference values for glomerular filtration rate: what do we really know?","volume":"27","author":"Delanaye","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1010","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","article-title":"Single-nephron glomerular filtration rate in healthy adults","volume":"376","author":"Denic","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1015","first-page":"17","article-title":"An age-calibrated definition of chronic kidney disease: rationale and benefits","volume":"37","author":"Delanaye","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1020","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1681\/ASN.2019030238","article-title":"CKD: a call for an age-adapted definition","volume":"30","author":"Delanaye","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1025","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.kint.2018.11.029","article-title":"Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors","volume":"95","author":"Gaillard","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1030","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Donor Nephrectomy Outcomes Research \u201cDONOR\u201d Network: proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression","volume":"70","author":"Garg","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2015.01.019","article-title":"A prospective controlled study of living kidney donors: three-year follow-up","volume":"66","author":"Kasiske","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/TP.0000000000003210","article-title":"Factors associated with residual kidney function and proteinuria after living kidney donation in the US published online ahead of print, 2020 Mar 2","volume":"105","author":"Augustine","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2015.01.017","article-title":"Gout after living kidney donation: a matched cohort study","volume":"65","author":"Lam","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.ajkd.2013.01.027","article-title":"A prospective controlled study of kidney donors: baseline and 6-month follow-up","volume":"62","author":"Kasiske","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/ajt.14525","article-title":"GFR \u2264 25 years postdonation in living kidney donors with \u201cvs. without\u201d a first-degree relative with ESRD","volume":"18","author":"Matas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.nefro.2018.02.008","article-title":"Factors associated with renal function compensation after donor nephrectomy","volume":"38","author":"Burballa","year":"2018","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1065","doi-asserted-by":"crossref","first-page":"E883","DOI":"10.3390\/jcm8060883","article-title":"The effect of donors\u2019 demographic characteristics in renal function post-living kidney donation. Analysis of a UK single centre cohort","volume":"8","author":"Bellini","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1070","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1600-6143.2006.01359.x","article-title":"Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation","volume":"6","author":"Rook","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1075","doi-asserted-by":"crossref","first-page":"F1550","DOI":"10.1152\/ajprenal.00064.2018","article-title":"Renal functional reserve capacity before and after living kidney donation","volume":"315","author":"van Londen","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1432-2277.2006.00400.x","article-title":"Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors","volume":"20","author":"Hawley","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1085","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1681\/ASN.2007101065","article-title":"Extended prognostic value of urinary albumin excretion for cardiovascular events","volume":"19","author":"Brantsma","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1090","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1111\/ajt.13869","article-title":"Recipient outcomes following transplantation of allografts from live kidney donors who subsequently developed end-stage renal disease","volume":"16","author":"Muzaale","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1681\/ASN.2019090964","article-title":"Kidney structural features from living donors predict graft failure in the recipient","volume":"31","author":"Issa","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1100","doi-asserted-by":"crossref","first-page":"F196","DOI":"10.1152\/ajprenal.00287.2017","article-title":"Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR","volume":"314","author":"van Londen","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10157-019-01774-x","article-title":"Development and validation of a new prediction model for graft function using preoperative marginal factors in living-donor kidney transplantation","volume":"23","author":"Matsukuma","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1110","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/ajt.13709","article-title":"A risk index for living donor kidney transplantation","volume":"16","author":"Massie","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1115","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/ajt.13917","article-title":"Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors","volume":"16","author":"Anjum","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in prior living kidney donors","volume":"18","author":"Wainright","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ajt.15089","article-title":"You can\u2019t get there from here: critical obstacles to current estimates of the ESRD risks of young living kidney donors","volume":"19","author":"Steiner","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMe1513891","article-title":"The risks of living kidney donation","volume":"374","author":"Steiner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ctr.12652","article-title":"Moving closer to understanding the risks of living kidney donation","volume":"30","author":"Steiner","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1140","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2017040375","article-title":"Synthesizing absolute and relative risks and the many unknowns to inform living kidney donors","volume":"28","author":"Poggio","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1145","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors","volume":"28","author":"Massie","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1150","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfr479","article-title":"Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effects of age, gender, obesity and scaling","volume":"27","author":"Peters","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12882-018-1126-8","article-title":"Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation","volume":"19","author":"Fenton","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2015.01.019","article-title":"A prospective controlled study of living kidney donors: three-year follow-up","volume":"66","author":"Kasiske","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1165","article-title":"Comparison of baseline GFR levels by age bands with 1 year, 5 year and 10 year outcomes in live donors - UK cohort study","author":"Krishnan","year":"2020","journal-title":"BTS"},{"issue":"Supl. 1","key":"10.1016\/j.nefroe.2022.07.001_bib1170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in prior living kidney donors","volume":"18","author":"Wainright","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1180","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.tp.0000277288.78771.c2","article-title":"Living kidney donors requiring transplantation: focus on African Americans","volume":"84","author":"Gibney","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2215\/CJN.11421116","article-title":"A case-based analysis of whether living related donors listed for transplant share ESRD causes with their recipients","volume":"12","author":"Matas","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1190","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/ajt.14671","article-title":"Causes and timing of end-stage renal disease after living kidney donation","volume":"18","author":"Matas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1600-6143.2010.03023.x","article-title":"\u2018Normal for now\u2019 or \u2018at future risk\u2019: a double standard for selecting young and older living kidney donors","volume":"10","author":"Steiner","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1200","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/ajt.13687","article-title":"Perioperative complications after living kidney donation: a national study","volume":"16","author":"Lentine","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2215\/CJN.03820413","article-title":"Hospitalizations following living donor nephrectomy in the United States","volume":"9","author":"Schold","year":"2014","journal-title":"Clin J AmSoc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/cc2873","article-title":"Clinical review: how to identify high-risk surgical patients","volume":"8","author":"Hall","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1215","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative metaanalysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1220","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1225","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"Lees","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10157-019-01842-2","article-title":"High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function","volume":"24","author":"Okubo","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-97-4-516","article-title":"Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study","volume":"97","author":"Springberg","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1240","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1245","article-title":"Microhematuria asintom\u00e1tica, Gu\u00edas Cl\u00ednicas","author":"Gonz\u00e1lez","year":"2020","journal-title":"Fisterra"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1250","doi-asserted-by":"crossref","first-page":"g6768","DOI":"10.1136\/bmj.g6768","article-title":"Investigating asymptomatic invisible haematuria","volume":"349","author":"Hole","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1255","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria \u201cAMH\u201d in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1260","doi-asserted-by":"crossref","first-page":"e0161802","DOI":"10.1371\/journal.pone.0161802","article-title":"X-linked and autosomal recessive alport syndrome: pathogenic variant features and further genotype-phenotype correlations","volume":"11","author":"Savige","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1265","series-title":"Nefrolog\u00eda al D\u00eda, consultado 2 febrero 2020","article-title":"S\u00edndrome de Alport y Hematurias Familiares","author":"Furlano","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1270","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","article-title":"Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1275","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2011.1141","article-title":"Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease","volume":"306","author":"Vivante","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1280","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ki.1996.30","article-title":"A prospective study of the natural history of idiopathic non-proteinuric hematuria","volume":"49","author":"Nieuwhof","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1285","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1681\/ASN.2015091018","article-title":"Renal function profile in white kidney donors: the first 4 decades","volume":"27","author":"Ibrahim","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1290","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.recesp.2012.02.005","article-title":"Magnitud y manejo de la hipercolesterolemia en la poblaci\u00f3n adulta de Espa\u00f1a, 2008-2010: el estudio ENRICA","author":"Guallar-Castill\u00f3n","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1295","first-page":"e298","article-title":"Diagnosis and management of the metabolic syndrome","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1300","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.transproceed.2011.02.058","article-title":"Association of the metabolic syndrome and long-term renal function in kidney donors","volume":"43","author":"Cuevas-Ramos","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12882-019-1214-4","article-title":"Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function","volume":"20","author":"Grupper","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1310","unstructured":"British Columbia Transplant Clinical Guidelines for Living Donor Kidney Transplantation. Available from: http:\/\/www.transplant.bc.ca\/Documents\/Clinical%20Guidelines%20for%20Living%20Donor%20Kidney%20Transplantation%202019.pdf"},{"issue":"4S1 Supl. 1","key":"10.1016\/j.nefroe.2022.07.001_bib1315","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1320","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009-10","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000381291","article-title":"Gout after living kidney donation: correlations with demographic traits and renal complications","volume":"41","author":"Lam","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12882-019-1588-3","article-title":"Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study","volume":"20","author":"Nishida","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1340","article-title":"Consumo y Bienestar Social","author":"Observador Espa\u00f1ol de las Drogas y las Adicciones, Ministerio de Sanidad","year":"2019","journal-title":"Gobierno de Espa\u00f1a"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1345","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2016.02.046","article-title":"Risk factors for rapid kidney function decline among African Americans: the Jackson Heart Study \u201cJHS\u201d","volume":"68","author":"Young","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1350","series-title":"Alcohol and primary health care: clinical guidelines on identification and brief interventions","author":"Anderson","year":"2005"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1355","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.surg.2019.03.016","article-title":"Obesity and long-term mortality risk among living kidney donors","volume":"166","author":"Locke","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00041552-200303000-00011","article-title":"Obesity- associated hypertension and kidney disease","volume":"12","author":"Hall","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1365","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1007\/s00464-019-07218-7","article-title":"Is obesity a contraindication for kidney donation?","volume":"34","author":"Schussler","year":"2019","journal-title":"Surg Endosc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1370","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.surg.2018.07.015","article-title":"Implications of excess weight on kidney donation: long-term consequences of donor nephrectomy in obese donors","volume":"164","author":"Serrano","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1375","doi-asserted-by":"crossref","first-page":"e13360","DOI":"10.1111\/ctr.13360","article-title":"Weight gain after kidney donation: association with increased risks of type 2 diabetes and hypertension","volume":"32","author":"Issa","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1380","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2215\/CJN.01350209","article-title":"Long-term renal function and cardiovascular disease risk in obese kidney donors","volume":"4","author":"Tavakol","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2054358119847203","article-title":"Changes in body weight before and after kidney donation","volume":"6","author":"Bugeja","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1390","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence awareness treatment control of hypertension in rural urban communities in high- middle-low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1395","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1400","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/tri.13576","article-title":"Increased long-term risk for hypertension in kidney donors \u2013 a retrospective cohort study","volume":"33","author":"Haugen","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-2277.2010.01148.x","article-title":"One-and five-year follow-ups on blood pressure and renal function in kidney donors","volume":"24","author":"Mjoen","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4103\/1319-2442.265463","article-title":"Prevalence and risk factors of hypertension following nephrectomy in living kidney donors","volume":"30","author":"Abdellaoui","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1415","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1111\/ajt.14713","article-title":"Hypertension after kidney donation: incidence predictors and correlates","volume":"18","author":"Sanchez","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1420","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/TP.0b013e3181c1e156","article-title":"A study of renal outcomes in African American living kidney donors","volume":"88","author":"Nogueira","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1425","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/TP.0b013e318240e9b9","article-title":"Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy","volume":"93","author":"Tent","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1430","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2215\/CJN.01240307","article-title":"Routine use of ambulatory blood pressure monitoring in potential living kidney donors","volume":"2","author":"Ommen","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000335070","article-title":"Living donor kidney donation: another form of white coat effect","volume":"35","author":"DeLoach","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2022.07.001_bib1445","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12902-019-0463-3","article-title":"Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe","volume":"20","author":"Kyrou","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1450","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12659\/AOT.895729","article-title":"The medically complex living kidney donor: glucose metabolism as principal cause of donor declination","volume":"21","author":"Guthoff","year":"2016","journal-title":"Ann Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1455","first-page":"1059","article-title":"Signaling pathways in diabetic nephropathy","volume":"31","author":"Kawanami","year":"2016","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1460","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ki.2008.664","article-title":"A potential living kidney donor with prediabetes","volume":"76","author":"Yang","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1465","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10157-017-1487-5","article-title":"No significant differences in short-term renal prognosis between living kidney donors with and without diabetes","volume":"22","author":"Shinzato","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1470","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0b013e3181d9e17b","article-title":"The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center","volume":"89","author":"Okamoto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1475","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20132018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1480","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1485","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-6143.2012.04321.x","article-title":"Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades","volume":"13","author":"Taler","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1490","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.TP.0000438625.91095.8b","article-title":"Prediabetic living kidney donors have preserved kidney function at 10 years after donation","volume":"97","author":"Chandran","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1495","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.transproceed.2019.03.082","article-title":"Utilization of HbA1c in screening living kidney donors with prediabetes","volume":"51","author":"Na","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1500","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-6143.2009.02944.x","article-title":"Diabetes after kidney donation","volume":"10","author":"Ibrahim","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1505","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/ajt.14416","article-title":"Renal consequences of diabetes after kidney donation","volume":"17","author":"Ibrahim","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1515","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.dsx.2017.11.004","article-title":"Prevalence of metabolic syndrome in Middle-East countries: meta-analysis of cross-sectional studies","volume":"12","author":"Ansarimoghaddam","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1520","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003\u20132012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1525","first-page":"20","article-title":"Metabolic syndrome and live kidney donor: is this syndrome a contraindication to donation?","volume":"29","author":"Hern\u00e1ndez","year":"2009","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1530","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1535","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/ajt.12369","article-title":"Association of metabolic syndrome with kidney function and histology in living kidney donors","volume":"13","author":"Ohashi","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1540","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2213-8587(13)70175-X","article-title":"Definition of intervention points in prediabetes","volume":"2","author":"Ferrannini","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1545","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"The Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males","volume":"67","author":"Kosaka","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1555","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ijo.2011.161","article-title":"Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4\/F4 study","volume":"36","author":"Kowall","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1560","doi-asserted-by":"crossref","first-page":"e010951","DOI":"10.1161\/JAHA.118.010951","article-title":"Change in cardiometabolic risk factors associated with magnitude of weight regain 3 years after a 1-year intensive lifestyle intervention in type 2 diabetes mellitus: the Look AHEAD Trial","volume":"8","author":"Berger","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1565","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1123\/jpah.2016-0632","article-title":"Effect of physical activity intervention in prediabetes: a systematic review with meta-analysis","volume":"14","author":"Jadhav","year":"2017","journal-title":"J Phys Act Health"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1570","first-page":"2065","article-title":"Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1575","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.diabres.2017.12.017","article-title":"High-intensity interval training versus continuous training on physiological and metabolic variables in prediabetes and type 2 diabetes: a meta-analysis","volume":"137","author":"De Nardi","year":"2018","journal-title":"Diabetes Res Clin Practic"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1580","first-page":"166","article-title":"Successful homotransplantations of the kidney in an identical twin","volume":"67","author":"Merrill","year":"1956","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1585","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1590","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1600-6143.2004.00364.x","article-title":"Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers","volume":"4","author":"Warren","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1595","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/TXD.0000000000000664","article-title":"The risk of transplant failure with HLA mismatch in first adult kidney allografts 2: living donors, summary, guide","volume":"3","author":"Williams","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/vox.12717","article-title":"International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: report of the Dubai Copenhagen and Toronto meetings","volume":"114","author":"Storry","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1605","first-page":"1132","article-title":"Ueber Agglutinationserscheinungen normalen menschlichen Blutes","volume":"14","author":"Landsteiner","year":"1901","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1610","series-title":"Technical Manual, 19th ed.","author":"Fung","year":"2017"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1615","first-page":"7","article-title":"tiempo de estandarizaci\u00f3n: grupo sangu\u00edneo \u00abO\u00bb \u201cletra\u201d, no \u00ab0\u00bb \u201ccero\u201d","author":"Lozano-Molero","year":"2004","journal-title":"Bol Soc Esp Transf Sang"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1620","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.tp.0000231697.15817.51","article-title":"Blood group A and B antigen expression in human kidneys correlated to A1\/A2\/B Lewis, an secretor status","volume":"82","author":"Breimer","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1625","first-page":"4528","article-title":"Blood group ABO-incompatible \u201cA2 to O\u201d kidney transplantation in human subjects: a clinical, serologic, and biochemical approach","volume":"19","author":"Rydberg","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1537-2995.1990.30290162894.x","article-title":"The gel test: a new way to detect red cell antigen-antibody reactions","volume":"30","author":"Lapierre","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1635","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-3148.2001.00321.x","article-title":"The ABO blood group system: historical background","volume":"11","author":"Watkins","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1640","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-3148.2001.00313.x","article-title":"ABO-incompatibility in solid organ transplantation","volume":"11","author":"Rydberg","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1645","unstructured":"Essential Guide to Blood Groups Singapore: Blackwell Publishing, 2007 Favor de proporcionar m\u00e1s informaci\u00f3n en la referencia 329"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1650","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/ajt.15258","article-title":"Assessing the utilization of high-resolution 2-field HLA typing in solid organ transplantation","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1655","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0198-8859(02)00382-8","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination I. Description of the algorithm","volume":"63","author":"Duquesnoy","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1660","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1665","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-transplant assessment of donor-reactive HLA-specific antibodies in renal transplantation: contraindication vs. risk","volume":"3","author":"Gebel","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1670","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MOT.0b013e32832d31c7","article-title":"Strategies for human leukocyte antigen antibody detection","volume":"14","author":"Bray","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"issue":"4\u20135","key":"10.1016\/j.nefroe.2022.07.001_bib1675","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1744-313X.2008.00768.x","article-title":"Solid phase testing in the HLA laboratory: implications for organ allocation","volume":"35","author":"Eckels","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1680","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/TP.0000000000002357","article-title":"Toward a sensible single-antigen bead cutoff based on kidney graft survival","volume":"103","author":"Wisse","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1685","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/tan.13693","article-title":"Out with the old, in with the new: virtual versus physical crossmatching in the modern era","volume":"94","author":"Morris","year":"2019","journal-title":"HLA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1690","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1695","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1700","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1705","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk \u201cSTAR\u201d 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"issue":"Sipl. 1","key":"10.1016\/j.nefroe.2022.07.001_bib1710","doi-asserted-by":"crossref","first-page":"38","DOI":"10.6002\/ect.MESOT2018.L41","article-title":"Anti-HLA antibody: the role of epitopes in organ transplantation","volume":"17","author":"Argani","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1715","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00251-019-01140-x","article-title":"PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation","volume":"72","author":"Geneugelijk","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1720","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/tan.13883","article-title":"HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level","volume":"96","author":"Kramer","year":"2020","journal-title":"HLA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1725","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1730","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2215\/CJN.13401118","article-title":"Preformed donor-specific HLA. Antibodies in living and deceased donor transplantation: a multicenter study","volume":"14","author":"Ziemann","year":"2019","journal-title":"Clinical J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1735","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfy349","article-title":"Positive luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis","volume":"34","author":"Buttigieg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1740","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2019.04.025","article-title":"Transplanting the untransplantable","volume":"75","author":"Holscher","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1745","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/tri.12012","article-title":"Living organ donation practices in Europe \u2013 results from an online survey","volume":"26","author":"Lennerling","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1750","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1148\/rg.307105032","article-title":"Multidetector CT of living renal donors: lessons learned from surgeons","volume":"30","author":"Sebasti\u00e0","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1755","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2214\/AJR.05.0983","article-title":"Utility of 16-MDCT angiography for comprehensive preoperative vascular evaluation of laparoscopic renal donors","volume":"186","author":"Raman","year":"2006","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1760","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11255-014-0671-8","article-title":"Maximizing the donor pool: left versus right laparoscopic live donor nephrectomy-systematic review and metaanalysis","volume":"46","author":"Liu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1765","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.transproceed.2012.07.143","article-title":"Transposition of iliac vessels in implantation of right living donor kidneys","volume":"44","author":"Ciudin","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1770","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/archsurg.2009.49","article-title":"Living donor kidney transplantation with multiple arteries: recent increase in modern era of laparoscopic donor nephrectomy","volume":"144","author":"Saidi","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1775","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.urology.2010.07.503","article-title":"Living donor kidney transplantation with multiple renal arteries in the laparoscopic era","volume":"77","author":"Tyson","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1780","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2012.11572.x","article-title":"Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy","volume":"111","author":"Olsburgh","year":"2013","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2022.07.001_bib1785","first-page":"S26","article-title":"The CARI guidelines. Kidney stones epidemiology","volume":"12","author":"Hughes","year":"2007","journal-title":"Nephrology \u201cCarlton\u201d"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1790","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.ju.0000101757.69344.de","article-title":"Ex vivo ureteroscopic treatment of calculi in donor kidneys at renal transplantation","volume":"171","author":"Rashid","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1795","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1800","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.eururo.2005.10.020","article-title":"Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients","volume":"49","author":"Becker","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1805","first-page":"53","article-title":"Donor transmitted malignancies","volume":"9","author":"Buell","year":"2004","journal-title":"Ann Trasplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1810","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.euf.2018.01.018","article-title":"Effectiveness and harms of using kidneys with small renal tumors from deceased or living donors as a source of renal transplantation: a systematic review","volume":"5","author":"Hevia","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1815","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1464-410X.2008.07562.x","article-title":"Kidneys from patients with small renal tumours: a novel source of kidneys for transplantation","volume":"102","author":"Nicol","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1820","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1464-410X.2005.05415.x","article-title":"Comparison of laparoscopic and open donor nephrectomy: a randomized controlled trial","volume":"95","author":"Simforoosh","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1825","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/SLA.0b013e318153fd13","article-title":"Laparoscopic versus open live donor nephrectomy in renal transplantation: a meta-analysis","volume":"247","author":"Nanidis","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1830","article-title":"EAU guidelines on renal transplantation","author":"Breda","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1835","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1432-2277.2008.00828.x","article-title":"A meta-analysis of mini-open versus standard open and laparoscopic living donor nephrectomy","volume":"22","author":"Antcliffe","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1840","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1432-2277.2006.00324.x","article-title":"Mini-incision open donor neprectomy as an alternative to classic lumbotomy: evolution of the open approach","volume":"19","author":"Kok","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1845","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/j.1600-6143.2010.03281.x","article-title":"Long-term follow-up of a randomized trial comparing laparoscopic and mini-incision open live donor nephrectomy","volume":"10","author":"Dols","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1850","unstructured":"https:\/\/www.novartis.es\/interlife"},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2022.07.001_bib1855","first-page":"S88","article-title":"The CARI guidelines. Surgical techniques in living donor nephrectomy","volume":"15","author":"Gibbons","year":"2010","journal-title":"Nephrology \u201cCarlton\u201d"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1860","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00423-014-1196-4","article-title":"Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome","volume":"399","author":"Fonouni","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1865","first-page":"CD006124","article-title":"Laparoscopic versus open nephrectomy for live kidney donors","volume":"11","author":"Wilson","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1870","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.transproceed.2012.07.152","article-title":"The safety and efficacy of laparoscopic donor nephrectomy for renal transplantation: an updated meta-analysis","volume":"45","author":"Yuan","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1875","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/end.2006.20.717","article-title":"Randomized trial of laparoscopic donor nephrectomy with and without hand assistance","volume":"20","author":"Bargman","year":"2006","journal-title":"J Endourol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1880","first-page":"795","article-title":"A comparison of hand-assisted and pure laparoscopic techniques in live donor nephrectomy","volume":"63","author":"Branco","year":"2008","journal-title":"Clinics \u201cSao Paulo\u201d"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1885","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijsu.2017.02.018","article-title":"Should hand-assisted retroperitoneoscopic nephrectomy replace the standard laparoscopic technique for living donor nephrectomy? A meta-analysis","volume":"40","author":"Elmaraezy","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1890","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/tri.12226","article-title":"Can right-sided hand-assisted retroperitoneoscopic donor nephrectomy be advocated above standard laparoscopic donor nephrectomy: a randomized pilot study","volume":"27","author":"Klop","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1895","doi-asserted-by":"crossref","first-page":"e13451","DOI":"10.1111\/ctr.13451","article-title":"Robot-assisted laparoscopic vs laparoscopic donor nephrectomy in renal transplantation: a meta-analysis","volume":"33","author":"Wang","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1900","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.juro.2008.04.028","article-title":"Single port transumbilical \u201cE-NOTES\u201d donor nephrectomy","volume":"180","author":"Gill","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1905","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2009.07.023","article-title":"Laparo-Endoscopic Single Site \u201cLESS\u201d versus standard laparoscopic left donor nephrectomy: matched pair comparison","volume":"57","author":"Canes","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1910","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.acuro.2011.04.007","article-title":"Pioneer experience in Spain with LESS nephrectomy in living donor","volume":"35","author":"Musquera","year":"2011","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2009.08.074","article-title":"Laparoendoscopic single-site pfannenstiel donor nephrectomy","volume":"75","author":"Andonian","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1920","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.juro.2010.06.138","article-title":"Laparoendoscopic single site live donor nephrectomy: initial experience","volume":"184","author":"Gimenez","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1925","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.urology.2009.03.048","article-title":"Laparoendoscopic single-site donor nephrectomy: a single-center experience","volume":"74","author":"Ganpule","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1930","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.acuro.2011.04.007","article-title":"Pioneer experience in spain with LESS nephrectomy in living donor","volume":"35","author":"Musquera","year":"2011","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1935","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/end.2010.0250","article-title":"First prize: standard laparoscopic donor nephrectomy versus laparoendoscopic single-site donor nephrectomy: a randomized comparative study","volume":"25","author":"Kurien","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1940","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bju.12202","article-title":"Pfannenstiel laparoendoscopic single-site \u201cLESS\u201d vs conventional multiport laparoscopic live donor nephrectomy: a prospective randomized controlled trial","volume":"112","author":"Richstone","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1945","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.urology.2011.04.077","article-title":"Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes","volume":"78","author":"Afaneh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1950","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/TP.0b013e3181fecfe6","article-title":"Single-site laparoscopic living donor nephrectomy offers comparable perioperative outcomes to conventional laparoscopic living donor nephrectomy at a higher cost","volume":"91","author":"Lunsford","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1955","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0b013e318262ddd6","article-title":"Single-port donor nephrectomy provides improved patient satisfaction and equivalent outcomes","volume":"257","author":"Barth","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1960","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2011.03.021","article-title":"Feasibility of transvaginal natural orifice transluminal endoscopic surgery-assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?","volume":"59","author":"Alcaraz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1965","doi-asserted-by":"crossref","first-page":"e13116","DOI":"10.1097\/MD.0000000000013116","article-title":"Staplers or clips?. A systematic review and meta-analysis of vessel controlling devices for renal pedicle ligation in laparoscopic live donor nephrectomy","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine \u201cBaltimore\u201d"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1970","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.sla.0000193841.43474.ec","article-title":"Fatal and nonfatal hemorrhagic complications of living kidney donation","volume":"243","author":"Friedman","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1975","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2008.11.010","article-title":"Analysis of techniques to secure the renal hilum during laparoscopic donor nephrectomy: review of the FDA database","volume":"74","author":"Hsi","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1980","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2009.06.035","article-title":"Laparoscopic kidney transplantation","volume":"57","author":"Rosales","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1985","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2017.08.028","article-title":"Robot-assisted kidney transplantation: the European experience","volume":"73","author":"Breda","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1990","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.euf.2018.07.014","article-title":"Guidelines on renal transplantation: update 2018","volume":"4","author":"Rodriguez Faba","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.nefroe.2022.07.001_bib1995","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s001470050256","article-title":"Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins","volume":"12","author":"de Boer","year":"1999","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2000","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/TP.0b013e3181ca5722","article-title":"The use of explanted internal iliac artery grafts in renal transplants with multiple arteries","volume":"89","author":"Firmin","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.transproceed.2006.10.205","article-title":"Saphenous vein interposition as a salvage technique for complex vascular situations during renal transplantation","volume":"39","author":"Oertl","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00268-011-1243-z","article-title":"Renal vein lengthening using gonadal vein reduces surgical difficulty in living-donor kidney transplantation","volume":"36","author":"Feng","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1399-0012.2008.00866.x","article-title":"Use of spiral vein graft in living donor renal transplantation","volume":"22","author":"Nghiem DD:","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.surg.2014.06.007","article-title":"One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial","volume":"157","author":"Orlando","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tri.12301","article-title":"Ureterovesical anastomotic techniques for kidney transplantation: a systematic review and meta-analysis","volume":"27","author":"Alberts","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2030","first-page":"159","article-title":"Why renal transplant from living donors gives better results than cadaver renal transplant?","volume":"28","author":"Guirado","year":"2008","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.transproceed.2019.10.001","article-title":"Comparison of graft outcome between donation after circulatory death and living-donor kidney transplantation","volume":"52","author":"Zhang","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2040","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.transproceed.2011.07.018","article-title":"Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation","volume":"43","author":"Pawlicki","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.avsg.2016.03.002","article-title":"Evaluation of the vascular surgical complications of renal transplantation","volume":"33","author":"Ammi","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2050","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0041-1345(02)02876-2","article-title":"Renal vein thrombosis after renal transplantation: an important cause of graft loss","volume":"34","author":"Giustacchini","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0003319710377076","article-title":"Management of transplant renal artery stenosis","volume":"62","author":"Seratnahaei","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/TP.0b013e31822a40ef","article-title":"Management of primary symptomatic lymphocele after kidney transplantation: a systematic review","volume":"92","author":"Lucewicz","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2065","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.transproceed.2010.04.016","article-title":"Kidney transplant ureteroneocystostomy techniques and complications: review of the literature","volume":"42","author":"Kayler","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-5347(05)64544-2","article-title":"Comparing Taguchi and Lich-Gregoir ureterovesical reimplantation techniques for kidney transplants","volume":"168","author":"Secin","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2075","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.transproceed.2008.08.040","article-title":"Ureteral complications in renal transplant recipients successfully treated with interventional radiology","volume":"40","author":"Kaskarelis","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00345-015-1673-6","article-title":"Robotic-assisted kidney transplantation: our first case","volume":"34","author":"Breda","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2085","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.eururo.2015.07.026","article-title":"Totally robotic approach with transvaginal insertion for kidney transplantation","volume":"68","author":"Doumerc","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.eururo.2017.02.020","article-title":"Minimally invasive laparoscopic, and robotic-assisted techniques versus open techniques for kidney transplant recipients: a systematic review","volume":"72","author":"Wagenaar","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2095","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00345-017-2006-8","article-title":"Robotic kidney transplantation: one year after the beginning","volume":"35","author":"Breda","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442842","article-title":"Effect of pneumoperitoneum on renal function and physiology in patients undergoing robotic renal surgery","volume":"9","author":"Sodha","year":"2016","journal-title":"Curr Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bju.14014","article-title":"Robot-assisted kidney transplantation: comparison of the first 40 cases of open vs robot-assisted transplantations by a single surgeon","volume":"121","author":"Tugcu","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11701-018-0781-x","article-title":"Robotic-assisted renal transplantation with total extraperitonealization of the graft: experience of 34 cases","volume":"12","author":"Adiyat","year":"2018","journal-title":"J Robot Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.purol.2017.10.002","article-title":"Robot-assisted renal transplantation using the retroperitoneal approach \u201cRART\u201d with more than one year follow up: description of the technique and results","volume":"28","author":"Bruyere","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bju.14247","article-title":"European experience of robot-assisted kidney transplantation: minimum of 1-year follow-up","volume":"122","author":"Territo","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/tri.12279","article-title":"Robot-assisted renal transplantation in the retroperitoneum","volume":"27","author":"Tsai","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/TP.0000000000000590","article-title":"Minimally invasive kidney transplantation: perioperative considerations and key 6-month outcomes","volume":"99","author":"Sood","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2135","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1442-2042.2007.01910.x","article-title":"Our experience with third renal transplantation: results, surgical techniques and complications","volume":"14","author":"Nourbala","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.eururo.2010.09.023","article-title":"Orthotopic kidney transplantation: an alternative surgical technique in selected patients","volume":"58","author":"Musquera","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2145","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.transproceed.2010.04.064","article-title":"Third and fourth kidney transplant: still a reasonable option","volume":"42","author":"Izquierdo","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.12659\/AOT.913300","article-title":"Surgical safety and efficacy of third kidney transplantation in the ipsilateral iliac fossa","volume":"24","author":"Domagala","year":"2019","journal-title":"Ann Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11934-020-0958-5","article-title":"Troubleshooting complex vascular cases in the kidney transplant recipient: vascular anomalies challenging vessel diseases, and procedural disasters","volume":"21","author":"Hevia","year":"2020","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2160","series-title":"Transplantation in patients with lower urinary tract anomalies In: European Textbook on Kidney Transplantation. Edited by Figueiredo A, Lled\u00f3-Garc\u00eda.","first-page":"337","author":"Da Costa","year":"2017"},{"issue":"Suppl. 2","key":"10.1016\/j.nefroe.2022.07.001_bib2165","first-page":"80","article-title":"Immunosuppression of the living-donor recipient","volume":"30","author":"Pascual","year":"2010","journal-title":"Nefrologia"},{"issue":"Suppl. 3","key":"10.1016\/j.nefroe.2022.07.001_bib2170","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes \u201cKDIGO\u201d Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2175","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/TP.0b013e3181fecfcb","article-title":"Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data","volume":"90","author":"Cai","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2185","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1681\/ASN.V8111771","article-title":"Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis","volume":"8","author":"Szczech","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2190","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-128-10-199805150-00004","article-title":"The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data","volume":"128","author":"Szczech","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2195","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tri.12043","article-title":"Selection of induction therapy in kidney transplantation","volume":"26","author":"Hardinger","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2200","first-page":"CD003897","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"2010","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20620","article-title":"Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model","volume":"20","author":"Jones-Hughes","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2210","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/TP.0b013e3181a2475f","article-title":"Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients","volume":"87","author":"Hardinger","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1592\/phco.31.6.566","article-title":"Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal","volume":"31","author":"Martin","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2220","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.intimp.2011.07.012","article-title":"Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin","volume":"11","author":"Lib\u00f3rio","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2225","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2230","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.TP.0000129812.68794.CC","article-title":"Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids","volume":"78","author":"Mourad","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2235","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation \u201cHarmony\u201d: an open-label, multicentre, randomised controlled trial","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF containing triple therapy","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2245","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.transproceed.2006.06.133","article-title":"Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation","volume":"38","author":"Al Najjar","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2250","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2255","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(14)61095-3","article-title":"Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation \u201cthe 3C Study\u201d: a randomised trial","volume":"384","author":"3C Study Collaborative Group","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2260","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2265","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2270","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2215\/CJN.03200319","article-title":"Infection-related mortality in recipients of a kidney transplant in Australia and New Zealand","volume":"14","author":"Chan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2275","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10245330400001942","article-title":"Fatal thrombocytopaenia temporally related to the administration of alemtuzumab \u201cMabCampath\u201d for refractory CLL despite early discontinuation of therapy","volume":"9","author":"Haider","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2280","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1600-6143.2006.01258.x","article-title":"Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab","volume":"6","author":"Kirk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2285","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1592\/phco.29.10.1166","article-title":"Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression","volume":"29","author":"Miller","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2290","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/01.tp.0000209825.91632.ea","article-title":"Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience","volume":"81","author":"Hardinger","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2295","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","article-title":"Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation","volume":"259","author":"Pilch","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2300","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.transproceed.2020.01.054","article-title":"Low-dose thymoglobulin vs basiliximab induction therapy in low-risk living related kidney transplant recipients: a prospective randomized trial","volume":"53","author":"Martinez-Mier","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2305","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1600-6143.2008.02378.x","article-title":"Monozygotic transplantation: concerns and opportunities","volume":"8","author":"Krishnan","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2310","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/TP.0b013e31818bd83d","article-title":"Renal transplantation in identical twins in United States and United Kingdom","volume":"86","author":"Kessaris","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gft447","article-title":"Calcineurin inhibitors in HLA-identical living related donor kidney transplantation","volume":"29","author":"Verghese","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2325","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/TP.0b013e31819634eb","article-title":"Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation","volume":"87","author":"Van de Wetering","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2330","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/TP.0b013e318194515c","article-title":"A prospective trial of a steroid-free\/calcineurin inhibitor minimization regimen in human leukocyte antigen \u201cHLA\u201d-identical live donor renal transplantation","volume":"87","author":"Walker","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2335","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2340","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1681\/ASN.2016070768","article-title":"Comparing outcomes between antibody induction therapies in kidney transplantation","volume":"28","author":"Koyawala","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2345","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.transproceed.2019.04.059","article-title":"Induction type and outcomes in HLA-DR mismatch kidney transplantation","volume":"51","author":"Sureshkumar","year":"2019","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2350","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of thymoglobulin versus atgam for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1399-0012.2007.00774.x","article-title":"A randomized trial of thymoglobulin vs. alemtuzumab \u201cwith lower dose maintenance immunosuppression\u201d vs. daclizumab in renal transplantation at 24 months of follow-up","volume":"22","author":"Ciancio","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2360","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/TP.0b013e3182472898","article-title":"Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression","volume":"93","author":"Sureshkumar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2365","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/TP.0b013e3181a235fd","article-title":"A randomized, doubleblind, placebocontrolled, study of single-dose rituximab as induction in renal transplantation","volume":"87","author":"Tyd\u00e9n","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2370","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"Van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2375","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/01.tp.0000418580.88642.e1","article-title":"A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up","volume":"94","author":"Tyd\u00e9n","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2380","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCRESAHA.111.248542","article-title":"B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions","volume":"109","author":"Kyaw","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2385","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/TP.0000000000000362","article-title":"A systematic review of the use of rituximab for desensitization in renal transplantation","volume":"98","author":"Macklin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2390","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/01.TP.0000112435.51747.63","article-title":"Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial","volume":"77","author":"Wiland","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12882-019-1293-2","article-title":"Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study","volume":"20","author":"Qiu","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2400","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2405","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00007890-200202150-00025","article-title":"Short course induction immunosuppression with thymoglobulin for renal transplant recipients","volume":"73","author":"Agha","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1432-2277.2006.00270.x","article-title":"Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation","volume":"19","author":"Wong","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2415","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e31816dd596","article-title":"Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients","volume":"85","author":"Gurk-Turner","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2420","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0b013e3181722fad","article-title":"Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report","volume":"85","author":"Stevens","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2425","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2430","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.tp.0000168436.76784.45","article-title":"2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?","volume":"80","author":"Wong","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2435","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2440","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2445","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation Favor de verificar. Las referencias 489 y 495 son las mismas","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2450","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus \u201cPrograf\u201d in combination with azathioprine or mycophenolate mofetil versus cyclosporine \u201cNeoral\u201d with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2455","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2460","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.2011010006","article-title":"Randomized trial of immunosuppressive regimens in renal transplantation","volume":"22","author":"Guerra","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.13666","article-title":"Kidney","volume":"16 Suppl 2","author":"Hart","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2470","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.TP.0000162980.68628.5A","article-title":"A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients","volume":"80","author":"Hardinger","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2475","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation Favor de verificar. Las referencias 489 y 495 son las mismas","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2480","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1600-6143.2006.01291.x","article-title":"Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study","volume":"6","author":"Kamar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2485","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ackd.2005.11.001","article-title":"Calcineurin nephrotoxicity","volume":"13","author":"Williams","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2490","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","article-title":"Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss","volume":"67","author":"Binet","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2495","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/00007890-200004270-00038","article-title":"Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison","volume":"69","author":"Higgins","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2500","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.tp.0000209411.66790.b3","article-title":"Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium","volume":"81","author":"Chan","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2505","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.tp.0000290678.06523.95","article-title":"Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients","volume":"84","author":"Bolin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2510","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2520","first-page":"007746","article-title":"Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients","author":"Wagner","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2525","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.TP.0000053753.43268.F0","article-title":"Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea","volume":"75","author":"Maes","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2530","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.tp.0000225760.09969.1f","article-title":"Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2535","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2540","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-199911270-00028","article-title":"Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients","volume":"68","author":"Gregoor","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2545","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/14.3.706","article-title":"Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study","volume":"14","author":"Smak Gregoor","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2550","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2005101070","article-title":"Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients","volume":"17","author":"van Hest","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2555","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.1990.tb00195.x","article-title":"Azathioprine and allopurinol: a potentially dangerous combination","volume":"228","author":"Venkat Raman","year":"1990","journal-title":"J Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2560","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199404150-00001","article-title":"Trends in the use of glucocorticoids in renal transplantation","volume":"57","author":"Hricik","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2565","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18 Suppl 1","author":"Hart","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2570","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000145435.80005.1E","article-title":"Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal","volume":"15","author":"Midtvedt","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2575","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/TP.0b013e31821bf157","article-title":"Recurrent glomerulonephritis under rapid discontinuation of steroids","volume":"91","author":"Kukla","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2580","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/TP.0000000000000274","article-title":"Transplantation between monozygotic twins: how identical are they?","volume":"98","author":"Day","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-3782(01)00171-2","article-title":"Mechanisms for the differences in monozygous twins","volume":"64","author":"Gringras","year":"2001","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2590","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.humimm.2007.02.004","article-title":"The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage","volume":"68","author":"Aydingoz","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2595","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/TP.0b013e3182033ef0","article-title":"Calcineurin inhibitor-free monotherapy in human leukocyte antigen-identical live donor renal transplantation","volume":"91","author":"Venot","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2600","first-page":"225","article-title":"De novo everolimus for recipients of kidney transplants from HLA identical donors","volume":"38","author":"Pontello","year":"2016","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12916-016-0772-6","article-title":"Steroid withdrawal after renal transplantation: a retrospective cohort study","volume":"15","author":"Haller","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2610","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004290.pub2","article-title":"Target of rapamycin inhibitors \u201cTOR-I; sirolimus and everolimus\u201d for primary immunosuppression in kidney transplant recipients","author":"Webster","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2615","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.12795","article-title":"A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients","volume":"14","author":"Lim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2620","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2625","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ajt.14048","article-title":"Early conversion to prednisolone\/everolimus as an alternative weaning regimen associates with beneficial renal transplant histology and function: The randomized-controlled MECANO trial","volume":"17","author":"Bemelman","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2630","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.14186","article-title":"Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: results of the randomized ELEVATE trial","volume":"17","author":"De Fijter","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2635","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/tri.12411","article-title":"Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study","volume":"27","author":"Lehner","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2640","first-page":"14","article-title":"Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trial","volume":"76","author":"Bouamar","year":"2018","journal-title":"Neth J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2645","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2650","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1111\/ajt.12459","article-title":"Long-term exposure to belatacept in recipients of extended criteria donor kidneys","volume":"13","author":"Charpentier","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2655","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2660","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1097\/TP.0000000000001755","article-title":"A randomized controlled clinical trial comparing belatacept with tacrolimus after de novo kidney transplantation","volume":"101","author":"De Graav","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2665","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to belatacept from a calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial","volume":"69","author":"Griny\u00f3","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2670","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40620-017-0411-0","article-title":"Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function acid-base derangement and mineral-bone metabolism","volume":"30","author":"Schulte","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2675","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1016\/j.transproceed.2014.07.003","article-title":"Conversion to belatacept-based immunosuppression therapy in renal transplant patients","volume":"46","author":"Paz","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2680","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-013-2665-7","article-title":"Likelihood of children with end-stage kidney disease in Europe to live with a functioning kidney transplant is mainly explained by nonmedical factors","volume":"29","author":"Harambat","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2685","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00467-014-2884-6","article-title":"Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN\/ERA\u2013EDTA registry","volume":"29","author":"Chesnaye","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2690","series-title":"Annual Report. \u201c20 March 2012, date last accessed\u201d","author":"NAPRTCS","year":"2012"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2695","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00467-010-1631-x","article-title":"Mortality risk in children after renal allograft failure: a NAPRTCS study","volume":"25","author":"Chen","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2700","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1600-6143.2006.01405.x","article-title":"Kidney transplantation without prior dialysis in children: the Eurotransplant experience","volume":"6","author":"Cransberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00467-003-1376-x","article-title":"Renal replacement therapy in children: data from 12 registries in Europe","volume":"19","author":"van der Heijden","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"S2","key":"10.1016\/j.nefroe.2022.07.001_bib2710","first-page":"1","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Nefrolog\u00eda \u201cS.E.N.\u201d y de la Organizaci\u00f3n Nacional de Trasplantes \u201cONT\u201d sobre trasplante renal de donante vivo","volume":"30","author":"Fern\u00e1ndez Fresnedo","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2715","unstructured":"Organizaci\u00f3n Nacional de trasplantes. Programa de donaci\u00f3n cruzada. 2015; 11\u201c2\u201d,11\u201c4\u201d 50 https:\/\/www.ont.es\/infesp\/DocumentosDeConsenso\/Programa%20Donaci%C3%B3n%20Renal%20Cruzada_actualizaci%C3%B3n_25062015.pdf. Favor de proporcionar fecha de consulta: d\u00eda, mes y a\u00f1o."},{"key":"10.1016\/j.nefroe.2022.07.001_bib2720","article-title":"Puesta en marcha de un Plan Nacional de Donaci\u00f3n Cruzada y Cadenas de trasplante renal en Espa\u00f1a. Expectativas de la donaci\u00f3n altruista","author":"Valent\u00edn","year":"2015","journal-title":"Tesis doctoral Universidad Complutense de Madrid"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2725","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.kint.2020.03.029","article-title":"Results in the ESPN\/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe","volume":"98","author":"Bonthuis","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2730","first-page":"55","article-title":"Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing","volume":"1","author":"Cecka","year":"1997","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2735","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ndt\/gfv313","article-title":"Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN\/ERA-EDTA Registry","volume":"31","author":"Lofaro","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"10084","key":"10.1016\/j.nefroe.2022.07.001_bib2740","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(17)30063-6","article-title":"Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN ERA\/EDTA registry analysis","volume":"389","author":"Chesnaye","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2745","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ki.2013.561","article-title":"Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period","volume":"86","author":"Van Stralen","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2750","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00467-012-2195-8","article-title":"Survival and transplantation outcomes of children less than 2 years of age with end-stage renal disease","volume":"27","author":"Alexander","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2755","first-page":"208","article-title":"Pediatric renal transplantation with considerations for successful outcomes Seminars in Pediatric Surgery Se ha completado la informaci\u00f3n de esta referencia: t\u00edtulo, fecha de publicaci\u00f3n y rango de p\u00e1ginas","volume":"15","author":"Salvatierra@@Jr","year":"2006","journal-title":"Favor de validarla"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2760","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/pan.13201","article-title":"Intraoperative hemodynamic factors predicting early postoperative renal function in pediatric kidney transplantation","volume":"27","author":"Michelet","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2765","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/TP.0000000000001372","article-title":"Age-dependent risk of graft failure in young kidney transplant recipients","volume":"101","author":"Kabor\u00e9","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2770","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/ndt\/gfx261","article-title":"The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology\/European Renal Association\u2013European Dialysis and Transplantation Association Registry study","volume":"32","author":"Chesnaye","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2775","doi-asserted-by":"crossref","first-page":"e015593","DOI":"10.1136\/bmjopen-2016-015593","article-title":"Transition structures and timing of transfer from paediatric to adult-based care after kidney transplantation in Germany: a qualitative study","volume":"7","author":"Pr\u00fcfe","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2780","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00467-014-2809-4","article-title":"Adherence to transition guidelines in European paediatric nephrology units","volume":"29","author":"Forbes","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2785","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1399-3046.2008.01054.x","article-title":"The relationship of donor source and age on short- and long-term allograft survival in pediatric renal transplantation","volume":"13","author":"Dale-Shall","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2790","doi-asserted-by":"crossref","first-page":"e13401","DOI":"10.1111\/petr.13401","article-title":"Transplantation of adult-size kidneys in small pediatric recipient: a single-center experience","volume":"23","author":"Muramatsu","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-011-1962-2","article-title":"Renal transplantation in infants and small children","volume":"27","author":"Herthelius","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2800","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/TP.0000000000000607","article-title":"Outcomes in kidney transplant recipients from older living donors","volume":"99","author":"Englum","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2805","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/petr.12700","article-title":"Long-term outcome of pediatric kidney transplantation: a single-center experience from Greece","volume":"20","author":"Fotios Papachristou","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2810","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TP.0b013e318298f9db","article-title":"Relative importance of HLA mismatch and donor age to graft survival in young kidney transplant recipients","volume":"96","author":"Foster","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2815","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0b013e3181e46a22","article-title":"Pediatric kidney transplantation: analysis of donor age, HLA match, and post-transplant non-hodgkin lymphoma: a collaborative transplant study report","volume":"90","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2820","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MOU.0b013e328302ede7","article-title":"Urological issues in pediatric renal transplantation","volume":"18","author":"Alan","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2825","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00467-008-0951-6","article-title":"Renal transplantation in children with thrombosis of the inferior vena cava requires careful assessment","volume":"23","author":"Salvatierra","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2830","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/TXD.0000000000000592","article-title":"Successful kidney transplantation in children with a compromised inferior vena cava","volume":"2","author":"Shishido","year":"2016","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2835","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00467-012-2140-x","article-title":"Treatments and outcomes for end stage renal disease following Wilms tumor","volume":"27","author":"Grigoriev","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2840","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/TRRM.S34043","article-title":"Pediatric kidney transplantation: a review","volume":"5","author":"Sharma","year":"2013","journal-title":"Transplant Research and Risk Management"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2845","doi-asserted-by":"crossref","first-page":"134","DOI":"10.21037\/tau.2018.06.17","article-title":"Urologic issues in pediatric transplant recipients","volume":"8","author":"Torricelli","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2850","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/petr.12567","article-title":"Kidney transplant in pediatric patients with severe bladder pathology","volume":"19","author":"Sierralta","year":"2015","journal-title":"Pediatr Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2855","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/gfz026","article-title":"Pre-existing malignancies in renal transplant candidates \u2013time to reconsider waiting times","volume":"34","author":"Watschinger","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2860","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00431-018-3238-3","article-title":"Renal replacement therapy in children with severe developmental disability: guiding questions for decision-making","volume":"177","author":"Willem","year":"2018","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2865","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12887","article-title":"Severe intellectual disability is not a contraindication to kidney transplantation in children","volume":"21","author":"Chen","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2870","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1097\/TP.0000000000001640","article-title":"Insights in transplanting complex paediatric renal recipients with vascular anomalies","volume":"101","author":"Chandak","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2875","doi-asserted-by":"crossref","first-page":"e13341","DOI":"10.1111\/petr.13341","article-title":"Outcomes of kidney transplants in pediatric patients with the vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, limb abnomalities association","volume":"23","author":"Diaz","year":"2018","journal-title":"Pediatr Transplan"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2880","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00268-019-05030-x","article-title":"Medical contraindications to transplant listing in the USA: a survey of adult and pediatric heart, kidney liver and lung programs","volume":"43","author":"Wall","year":"2019","journal-title":"Worl J Surg"},{"issue":"Suppl 4","key":"10.1016\/j.nefroe.2022.07.001_bib2885","first-page":"iv195","article-title":"Underweight, overweight and obesity in paediatric dialysis and renal transplant patients","volume":"38","author":"Bonthuis","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2890","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00467-017-3636-1","article-title":"Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death","volume":"32","author":"Ladhani","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2895","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00007890-198706000-00027","article-title":"Immunoadsorption and renal transplant in two patients with a major ABO incompatibility","volume":"43","author":"Bannett","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2900","first-page":"4538","article-title":"Present experiences in a series of 26 ABO-incompatible living donor renal allografts","volume":"19","author":"Alexandre","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2905","first-page":"1","article-title":"ABO-incompatible pediatric kidney transplantation in a single-center trial","volume":"14","author":"Ohta","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2910","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00007890-200109270-00010","article-title":"ABO-incompatible living-donor kidney transplantation in children","volume":"72","author":"Shishido","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2915","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyd\u00e9n","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2920","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1111\/ajt.12920","article-title":"ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone","volume":"14","author":"Masterson","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2925","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00467-019-04376-7","article-title":"ABO-incompatible pediatric kidney transplantation without antibody removal","volume":"35","author":"Kawamura","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2930","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/TP.0000000000001325","article-title":"Immune desensitization allows pediatric blood group incompatible kidney transplantation","volume":"101","author":"Stojanovic","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2935","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-015-3295-z","article-title":"Management of sensitized pediatric patients prior to renal transplantation","volume":"31","author":"Pirojsakul","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2940","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2010.34","article-title":"Sensitized renal transplant recipients: current protocols and future directions","volume":"6","author":"Gloor","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2945","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00467-015-3064-z","article-title":"Optimizing HLA matching in a highly sensitized pediatric patient using","volume":"30","author":"Nayak","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2950","first-page":"191","article-title":"Renal transplantation in sensitized children and young adults: a nationwide approach","volume":"32","author":"Dello Strologo","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2955","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.transproceed.2016.09.024","article-title":"Implementation of a national priority allocation system for hypersensitized patients in spain based on virtual crossmatch: initial results","volume":"48","author":"Valentin","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2960","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00467-017-3882-2","article-title":"Desensitisation strategies in high-risk children before kidney transplantation","volume":"33","author":"Sharma","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2965","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00467-019-04393-6","article-title":"Does HLA matching matter in the modern era of renal transplantation?","volume":"36","author":"Kim","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2970","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.transproceed.2020.03.003","article-title":"Critical behaviour and psychopathologic variables of the parent-child couple in living kidney transplantation","volume":"52","author":"Pistorio","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2975","doi-asserted-by":"crossref","first-page":"21e12924","DOI":"10.1111\/petr.12924","article-title":"Very small pediatric donor kidney transplantation in pediatric recipients","volume":"21","author":"Yaffe","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2980","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1148\/radiol.2293021098","article-title":"Living donor kidneys usefulness of multi-detector row CT for comprehensive evaluation","volume":"229","author":"Kim","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2985","first-page":"1","article-title":"Laparoscopic live-donor nephrectomy: outcome of allograft function in paediatric recipient","volume":"35","author":"Mart\u00ednez Urrutia","year":"2014","journal-title":"Dialogues in Pediatric Urology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2990","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparision of mortality in all patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib2995","series-title":"Trasplante renal de donante vivo, Nefrolog\u00eda al D\u00eda","author":"Guirado","year":"2019"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3000","unstructured":"ONT, Actividad de Donaci\u00f3n y Trasplante Espa\u00f1a, 2019Favor de proporcionar fecha de consulta: d\u00eda, mes y a\u00f1o.-->, Available from: https:\/\/www.ont.es\/infesp\/Memorias\/ACTIVIDAD%20DE%20DONACI%C3%93N%20Y%20TRASPLANTE%20ESPA%C3%91A%202019.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3005","series-title":"Datos globales de donaci\u00f3n y trasplante","author":"ONT","year":"2011"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3010","unstructured":"ONT 2012 https:\/\/www.ont.es\/infesp\/DocumentosDeConsenso\/PROTOCOLO%20PATHI_actualizaci%C3%B3n2018.pdf. Online"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3015","doi-asserted-by":"crossref","first-page":"e2635","DOI":"10.1097\/MD.0000000000002635","article-title":"Desensitization using Bortezumib and high dose immunoglobulin increased rate of decesed donor kidney transplantation","volume":"95","author":"Jeong","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3025","first-page":"205","article-title":"Problem\u00e1tica del trasplante renal en el paciente hiperinmunizado","volume":"15","author":"Cotorruelo","year":"1995","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.ajkd.2018.12.036","article-title":"Allocation of the highest quality kidneys transplant outcomes under the new kidney allocation system","volume":"73","author":"Sethi","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.kint.2017.07.018","article-title":"Kidney allocation based on proved acceptable antigens results in superior graft survival in highly sensitized patients","volume":"93","author":"Heidt","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3040","first-page":"185","article-title":"Implications for patients waiting for a kidney transplant of using the calculated panel reactive antibody (cPRA)","volume":"30","author":"Magri\u00e7o","year":"2016","journal-title":"Port J Nephrol Hypert"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3045","first-page":"93","article-title":"Single antigen flow beads for identification of human leukocyte antigen antibody specificities in hypersensitized patients with chronic renal failure","volume":"41","author":"Soy\u00f6d","year":"2016","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3050","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jfma.2017.09.008","article-title":"Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan","volume":"116","author":"Shen","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ctr.12335","article-title":"Desensitization in kidney transplantation: review and future perspectives","volume":"28","author":"Abu Jawdeh","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3060","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/01.tp.0000296122.19026.0f","article-title":"Pharmacodynamics of rituximab in kidney transplantation","volume":"84","author":"Gemberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/TP.0000000000001330","article-title":"32 doses of bortezomib for desensitization is not well tolerated and is associated with only modest reductions in anti-HLA antibody","volume":"101","author":"Moreno Gonzales","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3070","first-page":"563","article-title":"Trasplante renal procedente de donante vivo HLA incompatible: Eficacia y pron\u00f3stico en 32 pacientes tras desensibilizaci\u00f3n","volume":"37","author":"Fernandez","year":"2017","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3075","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"International Society of Nephrology","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/qjmed\/hcs154","article-title":"Incompatible kidney transplantation: a brief overview of the past, present and future","volume":"105","author":"Sharif","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3085","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/ndt\/gfq264","article-title":"Immunoadsorption in nephrology and kidney transplantation","volume":"25","author":"Schwenger","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3095","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Eng J Med"},{"issue":"1 Supl 1","key":"10.1016\/j.nefroe.2022.07.001_bib3100","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.tmrv.2009.09.010","article-title":"The use of immunoglobulin therapy for patients undergoing solid organ transplantation:An evidence-based practice guideline","volume":"24","author":"Shehata","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3105","doi-asserted-by":"crossref","first-page":"e13560","DOI":"10.1111\/ctr.13560","article-title":"Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: a systematic review and meta-analysis","volume":"33","author":"Bourassa-Blanchette","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy outcomes, and cost-effectiveness of desensitization using IVIG and rituximab","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-6143.2010.03400.x","article-title":"Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients","volume":"11","author":"Jordan","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/MNH.0b013e328365b3b9","article-title":"Transplanting the highly sensitized patients: trials and tribulations","volume":"22","author":"Hariharan","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3135","first-page":"6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sheti","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3140","series-title":"Human CMV hyperimmunoglobulin for intravenous use. Product Monograph","author":"Cytotect\u00ae CP Biotest","year":"2013"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3145","series-title":"Servicios Sociales e Igualdad. Informe de Posicionamiento Terap\u00e9utico de Eculizumab (Soliris\u00ae) en el S\u00edndrome Hemol\u00edtico Ur\u00e9mico at\u00edpico","author":"Ministerio de Sanidad","year":"2014"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3150","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3155","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"issue":"S2","key":"10.1016\/j.nefroe.2022.07.001_bib3165","first-page":"62","article-title":"IMLIFIDASE for desensitization in sensitized kidney tranpslant patients: pooled analysis of Phase 2 trials","volume":"32","author":"Winstedt","year":"2019","journal-title":"Transplant Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3170","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A phase I\/II trial of the interleukin-6 receptor\u2013specific humanized monoclonal (tocilizumab)+intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/TP.0000000000002462","article-title":"Novel therapuetics approaches to allosensitization and antibody mediated rejection","volume":"103","author":"Jordan","year":"2019","journal-title":"Tranplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3185","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/TP.0000000000001619","article-title":"Kidney transplant with low levels of DSA or low positive bflow crossmatch: an underappreciated option for highlysensitized transplant candidates","volume":"101","author":"Schinstock","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00467-019-4192-7","article-title":"Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)\u2014a question to be addressed in a scientific way","volume":"34","author":"Ariceta","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3195","series-title":"Complication from desensitization kidney transplantation in sensitized patients","author":"Duck Jong","year":"2019"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3205","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.kint.2017.04.004","article-title":"Are sensitized patients better of with a desensitization transplant or waiting on dialysis?","volume":"91","author":"Clayton","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1681\/ASN.2014090894","article-title":"Immune sensitization and mortality in wait-listed kidney transplant candidates","volume":"27","author":"Sapir-Pichhadze","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12882-019-1625-2","article-title":"Transplant outcomes in positive complement-dependent cytotoxicityversus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study","volume":"20","author":"Kim","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/TP.0b013e318176ae2c","article-title":"Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience","volume":"86","author":"Magee","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-2277.2010.01138.x","article-title":"Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks","volume":"24","author":"Rogers","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/TP.0b013e318253f7b6","article-title":"Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients","volume":"94","author":"Alachkar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40472-013-0002-5","article-title":"State of the art practices and policies in kidney paired donation","volume":"1","author":"Cole","year":"2014","journal-title":"Curr Transpl Rep"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3250","first-page":"662","article-title":"Desensitization protocol for highly sensitized renal transplant patients: a single-center experience","volume":"22","author":"Kute","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3260","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3265","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0b013e31822dc38d","article-title":"Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch","volume":"92","author":"Higgings","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3270","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ajt.15397","article-title":"Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies","volume":"19","author":"Glotz","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3275","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcome of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3280","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ndt\/gfw027","article-title":"Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection","volume":"31","author":"Schwaiger","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.transproceed.2012.08.007","article-title":"Desensitizitacion combined with paired exchange leads to successful transplantation in high sensitized kidney transplant recipeints: strategy andreport of five cases","volume":"45","author":"Yabu","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3290","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ki.2013.206","article-title":"Kidney paired donation in the presence of donor-specific antibodies","volume":"84","author":"Blumberg","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3295","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":"Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis","volume":"8","author":"Opeltz","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3300","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.2215\/CJN.03710411","article-title":"Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin","volume":"6","author":"Kahwaji","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3305","doi-asserted-by":"crossref","first-page":"5672523","DOI":"10.1155\/2017\/5672523","article-title":"Impact of desensitization on antiviral immunity in HLA-sensitized kidney transplant recipients","volume":"2017","author":"Toyoda","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3310","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.transproceed.2015.09.025","article-title":"Desensitization before living kidney transplantation in highly HLS sensitized patient: a single-center study","volume":"47","author":"De Suosa-Amorin","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/TP.0b013e31821c93bb","article-title":"Luminex-based desensitization protocols: the University of Wisconsin initial experience","volume":"92","author":"Niederhaus","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3320","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/tri.13269","article-title":"Outcome of the risk-stratified desensitization protocol in donor-specific antibody-positive living kidney transplant recipients: a retrospective study","author":"Okada","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3325","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/ajt.14392","article-title":"The incremental cost of incompatible living donor kidney transplantation: a national cohort analys","volume":"17","author":"Axelrod","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/tri.13532","article-title":"Desensitization strategies: is it worth it?","volume":"33","author":"Kuppachi","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3335","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/ajt.14744","article-title":"The first 9 years of kidney paired donation through the National Kidney Registry: characteristics of donors and recipients compared to national live donor transplant registries","volume":"18","author":"Flechner","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.compbiomed.2019.03.013","article-title":"KDPGUI: An interactive application for optimization and management of a virtual kidney paired donation program","volume":"108","author":"Bray","year":"2019","journal-title":"Comput Biol Med"},{"issue":"S1","key":"10.1016\/j.nefroe.2022.07.001_bib3345","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3350","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3181\/00379727-113-28399","article-title":"Human renal homotransplantation in the presence of blood group incompatibilities","volume":"113","author":"Starzl","year":"1963","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-196703000-00046","article-title":"Report from kidney transplant registry: analysis of variables in the function of human kidney transplants: I. Blood group compatibility and splenectomy","volume":"5","author":"Gleason","year":"1967","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3360","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199801270-00014","article-title":"Long-term results of ABO-incompatible living kidney transplantation: a single-center experience","volume":"65","author":"Tanabe","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3365","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1600-6143.2004.00464.x","article-title":"Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan","volume":"4","author":"Takahashi","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3370","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.TP.0000136263.46262.0D","article-title":"ABO-incompatible kidney transplantation","volume":"78","author":"Stegall","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3375","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.294.13.1655","article-title":"Clinical results from transplanting incompatible live kidney donor\/recipient pairs using kidney paired donation","volume":"294","author":"Montgomery","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3380","first-page":"208","article-title":"Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later","volume":"2","author":"Squifflet","year":"2004","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3385","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","author":"Tyd\u00e9n","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3390","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-3089.2006.00292.x","article-title":"The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy","volume":"13","author":"Tyd\u00e9n","year":"2006","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3395","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ctr.12759","article-title":"Borderline rejection in ABO-incompatible kidney transplantation","volume":"30","author":"S\u00e1nchez-Escuredo","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3400","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.nefro.2016.05.022","article-title":"Failed ABO incompatible high titers kidney transplant using bortezomib. Case report","volume":"36","author":"De Sousa-Amorim","year":"2016","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3405","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.transproceed.2015.08.021","article-title":"Desensitization in ABO-incompatible kidney transplantation with low ABO iso-agglutinin titers","volume":"47","author":"Gelpi","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3410","first-page":"54","article-title":"ABO incompatible living donor kidney transplantation: A dream come true. Experience of Hospital Cl\u00ednic of Barcelona","volume":"30","author":"Oppenheimer","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3415","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jca.21779","article-title":"Successful use of nonantigen-specific immunoadsorption with antihuman Ig-columns in kidney graft antibody-mediated rejection","volume":"35","author":"Montagud-Marrahi","year":"2020","journal-title":"J Clin Apher"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3420","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.nefro.2019.02.010","article-title":"ABO incompatible live donor renal transplant. Study of 48 patients after desensitization","volume":"39","author":"Rivera","year":"2019","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3425","series-title":"Nacional de Trasplantes (ONT). Registro Espa\u00f1ol de Donante Vivo Renal","author":"Organizaci\u00f3n","year":"2010"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3430","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jca.21312","article-title":"Significance of isoagglutinin titer in ABO-incompatible kidney transplantation","volume":"29","author":"Won","year":"2014","journal-title":"J Clin Apher"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3435","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/nep.13412","article-title":"Clinical significance of isoagglutinin titre with the current desensitization protocol in ABO-incompatible kidney transplantation","volume":"24","author":"Baek","year":"2019","journal-title":"Nephrology"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3440","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ajt.13616","article-title":"Economic impacts of ABO-incompatible live donor kidney transplantation: a national study of medicare-insured recipients","volume":"16","author":"Axelrod","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3445","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1111\/trf.13770","article-title":"Clinical outcomes with ABO antibody titer variability in a multicenter study of ABO-incompatible kidney transplantation in the United Kingdom","volume":"56","author":"Bentall","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3450","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/trf.15672","article-title":"ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization","volume":"60","author":"Kim","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3455","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/ctr.12913","article-title":"Higher Anti-A\/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch","volume":"31","author":"De Santis","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3460","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","author":"Okumi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3465","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10157-016-1321-5","article-title":"Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation","volume":"21","author":"Takahashi","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3470","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1600-6143.2001.001003296.x","article-title":"Transplantation of ABO Group A2 kidneys from living donors into Group O and B recipients","volume":"1","author":"Sorensen","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3475","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.transproceed.2010.09.058","article-title":"Impact of pretransplant intravenous immunoglobulin administration on anti-AB0 antibody levels in ab0-incompatible living donor kidney transplantation","volume":"42","author":"Renner","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3480","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrneph.2015.144","article-title":"Strategies to overcome the ABO barrier in kidney transplantation","volume":"11","author":"B\u00f6hmig","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3485","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes. A meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3490","doi-asserted-by":"crossref","first-page":"e13591","DOI":"10.1111\/ctr.13591","article-title":"Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: a single-center Japanese cohort study","volume":"33","author":"Kakuta","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3495","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e31824836ae","article-title":"ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption","volume":"93","author":"Morath","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3500","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/tri.13482","article-title":"Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption \u2013 a retrospective study","volume":"32","author":"Speer","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3505","first-page":"401","article-title":"Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis","volume":"12","author":"Han","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3510","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/gfr237","article-title":"The efficacy of antigen-specific immunoadsorption and rebound of anti-A\/B antibodies in ABO-incompatible kidney transplantation","volume":"26","author":"Genberg","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3515","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000000933","article-title":"Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review meta-analysis","volume":"100","author":"Lo","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3520","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jamcollsurg.2017.12.026","article-title":"Landscape of ABO-incompatible live donor kidney transplantation in the US","volume":"226","author":"Mustian","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3525","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/ajt.14013","article-title":"Prospective analyses of circulating B cell subsets in ABO-compatible and ABO-incompatible kidney transplant recipients","volume":"17","author":"Schl\u00f6\u00dfer","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3530","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/tri.12482","article-title":"Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation","volume":"28","author":"Ishida","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3535","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2008.00821.x","article-title":"Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients","volume":"22","author":"Toki","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3540","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after A.B.O. antibody reduction: results from 101 centers","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3545","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/tri.12995","article-title":"Increased risk of infection-associated death with incompatible kidney transplantations","volume":"30","author":"Morath","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3550","doi-asserted-by":"crossref","first-page":"e13071","DOI":"10.1111\/ctr.13071","article-title":"Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: advantages and disadvantages of rituximab pretreatment","volume":"31","author":"Okada","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3555","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ki.2013.291","article-title":"Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation","volume":"85","author":"Ashimine","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3560","first-page":"491","article-title":"Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization","author":"Boothpur","year":"2009","journal-title":"Clin Transpl"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3565","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ki.2015.253","article-title":"The emerging role of complement inhibitors in transplantation","volume":"88","author":"Fr\u00e9meaux-Bacchi","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3570","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/trf.13119","article-title":"Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion","volume":"55","author":"Fata","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3575","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2215\/CJN.04540709","article-title":"Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly H.L.A. sensitized patients","volume":"4","author":"Kahwaji","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3580","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2008030279","article-title":"C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts","volume":"20","author":"Haas","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3585","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000001403","article-title":"Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation","volume":"101","author":"Ishihara","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3590","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-199108000-00006","article-title":"Immunopathology of hyperacute xenograft rejection in a swine-to-primate model","volume":"52","author":"Platt","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3595","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jca.21390","article-title":"ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange","volume":"30","author":"Yabu","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3600","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trre.2017.01.003","article-title":"Kidney paired exchange and desensitization: strategies to transplant the difficult to match kidney patients with living donors","volume":"31","author":"Pham","year":"2017","journal-title":"Transplant Rev"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3610","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/TXD.0000000000000695","article-title":"The UK National Registry of ABO and HLA antibody incompatible renal transplantation: pretransplant factors associated with outcome in 879 transplants","volume":"3","author":"Pankhurst","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3615","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21037\/tau.2019.03.05","article-title":"Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience","volume":"8","author":"Okumi","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3620","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3625","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000000029","article-title":"Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of medicare-insured recipients","volume":"98","author":"Lentine","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3630","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/TP.0b013e318299dc0e","article-title":"Cancer risk after ABO-incompatible living-donor kidney transplantation","volume":"96","author":"Hall","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3635","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.transproceed.2011.11.048","article-title":"Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy","volume":"44","author":"Yamamoto","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3640","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/tri.12969","article-title":"Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study","volume":"30","author":"Lonze","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3645","doi-asserted-by":"crossref","first-page":"e12418","DOI":"10.1111\/xen.12418","article-title":"Accommodation in ABO-incompatible organ transplants","volume":"25","author":"Garcia de Mattos Barbosa","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3650","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.coi.2004.07.004","article-title":"Antibody, complement and accommodation in ABO-incompatible transplants","volume":"16","author":"King","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3655","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.RES.0000216071.87981.16","article-title":"Differential regulation of endothelial cell activation by complement and interleukin 1alpha","volume":"98","author":"Brunn","year":"2006","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"10.1016\/j.nefroe.2022.07.001_bib3660","first-page":"94","article-title":"El donante incompatible en trasplante renal de donante vivo","volume":"30","author":"Guirado","year":"2010","journal-title":"Nefrolog\u00eda"},{"issue":"3, Suppl. 2","key":"10.1016\/j.nefroe.2022.07.001_bib3665","first-page":"5","article-title":"The case for a living emotionally related international kidney donor exchange registry","volume":"18","author":"Rapaport","year":"1986","journal-title":"Transplant Proc"},{"issue":"1\u20132","key":"10.1016\/j.nefroe.2022.07.001_bib3670","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0041-1345(98)01659-5","article-title":"Exchange-donor program in kidney transplantation","volume":"31","author":"Park","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3675","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/ndt\/gfr155","article-title":"Kidney paired donation","volume":"26","author":"Wallis","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3680","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1600-6143.2005.01024.x","article-title":"The Dutch national living donor kidney exchange program","volume":"5","author":"de Klerk","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3685","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/TP.0b013e3181901a3d","article-title":"Early experience of paired living kidney donation in the United Kingdom","volume":"86","author":"Johnson","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3690","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2054-3581-1-6","article-title":"Foundations and principles of the Canadian living donor paired exchange program","volume":"1","author":"Malik","year":"2014","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3695","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/tri.12373","article-title":"Increasing access to renal transplantation in India through our single-center kidney paired donation program: a model for the developing world to prevent commercial transplantation","volume":"27","author":"Kute","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3700","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/ndt\/gfu309","article-title":"Kidney paired donation: principles, protocols and programs","volume":"30","author":"Ferrari","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3705","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/ajt.12189","article-title":"Center-level utilization of kidney paired donation","volume":"13","author":"Massie","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3710","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1600-6143.2009.02745.x","article-title":"Successful expansion of the living donor pool by alternative living donation programs","volume":"9","author":"Roodnat","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3715","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/TP.0000000000000455","article-title":"The Canadian kidney paired donation program: a national program to increase living donor transplantation","volume":"99","author":"Cole","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3720","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/tri.12405","article-title":"Outcomes of shipped live donor kidney transplants compared with traditional living donor kidney transplants","volume":"27","author":"Treat","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3725","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ajt.14597","article-title":"Shipping living donor kidneys and transplant recipient outcomes","volume":"18","author":"Treat","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3730","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/ajt.12734","article-title":"Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program","volume":"14","author":"Baxter-Lowe","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3735","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1097\/TP.0000000000002691","article-title":"Clinical relevance of posttransplant DSAs in patients receiving desensitization for HLA-incompatible kidney transplantation","volume":"103","author":"Vo","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3740","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/TP.0000000000002664","article-title":"International cooperation for kidney exchange success","volume":"103","author":"Valent\u00edn","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3745","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(06)69115-0","article-title":"Domino paired kidney donation: a strategy to make best use of live non-directed donation","volume":"368","author":"Montgomery","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3750","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa0803645","article-title":"A nonsimultaneous, extended, altruistic-donor chain","volume":"360","author":"Rees","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3755","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/TP.0b013e318181fe3b","article-title":"Ingredients for a successful living donor kidney exchange program","volume":"86","author":"de Klerk","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3760","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejor.2019.09.006","article-title":"Modelling and optimisation in European Kidney Exchange Programmes","volume":"291","author":"Bir\u00f3","year":"2019","journal-title":"Eur J Op Res"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3765","article-title":"The Spanish Kidney Exchange Model: study of computation-based alternatives to the current procedure","volume":"10259","author":"Bofill","year":"2017","journal-title":"Artificial Intelligence in Medicine"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3770","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/TP.0000000000000054","article-title":"Assessing the efficacy of kidney paired donation\u2014performance of an integrated three-site program","volume":"98","author":"Li","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3775","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/TP.0000000000002947","article-title":"Ten years of kidney paired donation at Mayo Clinic: the benefits of incorporating ABO\/HLA compatible pairs","volume":"104","author":"Basu","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3780","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1600-6143.2007.01935.x","article-title":"Expanding kidney paired donation through participation by compatible pairs","volume":"7","author":"Gentry","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3785","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e3182a01311","article-title":"ABO-incompatible matching significantly enhances transplant rates in kidney paired donation","volume":"96","author":"Ferrari","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3790","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.293.15.1883","article-title":"Kidney paired donation and optimizing the use of live donor organs","volume":"293","author":"Segev","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3795","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMc1004959","article-title":"Kidney paired donation in live-donor kidney transplantation","volume":"363","author":"Bingaman","year":"2010","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3800","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/TP.0b013e3181908f60","article-title":"Hurdles, barriers, and successes of a national living donor kidney exchange program","volume":"86","author":"de Klerk","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3805","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3810","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0b013e3182612967","article-title":"High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation","volume":"94","author":"Ferrari","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3815","series-title":"Memorias de actividad de donaci\u00f3n y trasplante renal. 2019. consultado May","author":"ONT","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3820","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/tri.12719","article-title":"Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time","volume":"29","author":"Allen","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3825","series-title":"Action CA15210: European Network for Collaboration on Kidney Exchange Programmes (ENCKEP). consutado","author":"Handbook of the COST","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3830","series-title":"Department of Health & Human Services. National data, Donors Recovered: January 1, 1988 - April 30, 2020. consultado May","author":"US","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3835","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-6143.2003.00019.x","article-title":"The living anonymous kidney donor: lunatic or saint?","volume":"3","author":"Henderson","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3840","series-title":"Department of Health & Human Services National data, Donors Recovered: January 1, 1988 - July 31, 2017","author":"US","year":"2017"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3845","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/j.1600-6143.2009.02747.x","article-title":"Clinical outcomes of multicenter domino kidney paired donation","volume":"9","author":"Lee","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3850","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5500\/wjt.v7.i1.64","article-title":"International kidney paired donation transplantations to increase kidney transplant of O group and highly sensitized patient: first report from India","volume":"7","author":"Kute","year":"2017","journal-title":"World J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3855","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v8.i3.52","article-title":"Kidney exchange transplantation current status, an update and future perspectives","volume":"8","author":"Kute","year":"2018","journal-title":"World J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3860","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/TXD.0000000000000847","article-title":"Recipient outcomes from nondirected live kidney donors: a UK-based cohort study","volume":"4","author":"Nath","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3865","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-6143.2010.03034.x","article-title":"Altruistic donor triggered domino-paired kidney donation for unsuccessful couples from the kidney-exchange program","volume":"10","author":"Roodnat","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3870","unstructured":"U.K. Activity Report in organ Donation 2017-2018. Available from: https:\/\/nhsbtmediaservices.blob.core.windows.net\/organ-donation-assets\/pdfs\/activity_report_2017_18.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3875","series-title":"Actividad de donaci\u00f3n y trasplante. Holanda 2018. Dutch Transplant Foundation. consultado May","author":"Foundation","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3880","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/TP.0000000000000340","article-title":"Motivations, outcomes, and characteristics of unspecified (nondirected altruistic) kidney donors in the United Kingdom","volume":"98","author":"Maple","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3885","doi-asserted-by":"crossref","first-page":"234","DOI":"10.12659\/AOT.913827","article-title":"Living anonymous renal donors do not regret: intermediate and long-term follow-up with a focus on motives and psychosocial outcomes","volume":"24","author":"Wadstr\u00f6m","year":"2019","journal-title":"Ann Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3890","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10654-016-0168-0","article-title":"Live kidney donation: are concerns about long-term safety justified?\u2014a methodological review","volume":"32","author":"Janki","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3895","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/TP.0000000000002489","article-title":"Informative for decision making? The spectrum and consistency of outcomes after living kidney donation reported in trials and observational studies","volume":"103","author":"Hanson","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3900","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1136\/bmj.e1203","article-title":"Cardiovascular disease in kidney donors: matched cohort study","volume":"344","author":"Garg","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3905","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.12822","article-title":"Mortality and cardiovascular disease among older live kidney donors","volume":"14","author":"Reese","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3910","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M17-1235","article-title":"Mid- and long-term health risks in living kidney donors: a systematic review and meta analysis","volume":"168","author":"O\u2019Keeffe","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3915","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00007890-199710150-00007","article-title":"Kidney donors live longer","volume":"64","author":"Fehrman-Ekholm","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3920","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/TP.0b013e318192dc95","article-title":"Short- and long-term donor outcomes after kidney donation: analysis of 601 cases over a 35-year period at Japanese single center","volume":"87","author":"Okamoto","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3925","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.04020419","article-title":"Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy","volume":"14","author":"Holscher","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3930","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/tri.13576","article-title":"Increased long-term risk for hypertension in kidney donors \u2013 a retrospective cohort study","volume":"33","author":"Haugen","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3935","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1111\/ajt.14713","article-title":"Hypertension after kidney donation: incidence, predictors, and correlates","volume":"18","author":"Sanchez","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3940","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jamcollsurg.2008.08.022","article-title":"Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and nutrition examination survey, 1999 to 2004","volume":"207","author":"Nguyen","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3945","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/TP.0000000000002411","article-title":"Early hypertension and diabetes after living kidney donation: a national cohort study","volume":"103","author":"Holscher","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3950","doi-asserted-by":"crossref","first-page":"e13696","DOI":"10.1111\/ctr.13696","article-title":"Associations of obesity with antidiabetic medication use after living kidney donation: an analysis of linked national registry and pharmacy fill records","volume":"33","author":"Lentine","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3955","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.kint.2016.10.014","article-title":"Obesity increases the risk of end-stage renal disease among living kidney donors","volume":"91","author":"Locke","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3960","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression","volume":"70","author":"Garg","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3965","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2215\/CJN.02110213","article-title":"The unjustified classification of kidney donors as patients with CKD: critique and recommendations","volume":"8","author":"Matas","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3970","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2011111080","article-title":"The natural history of residual renal function in transplant donors","volume":"23","author":"Mueller","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3975","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI78885","article-title":"Longitudinal study of living kidney donor glomerular dynamics after nephrectomy","volume":"125","author":"Lenihan","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3980","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3985","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3990","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib3995","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4000","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1046\/j.1523-1755.2002.00270.x","article-title":"Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4005","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2013.04.010","article-title":"CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) Study: interactions with age, sex, and race","volume":"62","author":"Hui","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"Van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4030","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1993.156","article-title":"Forty-five year follow-up after uninephrectomy","volume":"43","author":"Narkun-Burgess","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ckj\/sfz012","article-title":"Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors","volume":"12","author":"Gonz\u00e1lez-Rinne","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s40472-017-0171-8","article-title":"Donation, not disease! A multiple-hit hypothesis on development of post-donation kidney disease","volume":"4","author":"Cheng","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4050","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/ndt\/gfv458","article-title":"Estimated nephron number of the remaining donor kidney: impact on living kidney donor outcomes","volume":"31","author":"Schachtner","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/ctr.12321","article-title":"Low birthweight and risk of albuminuria in living kidney donors","volume":"28","author":"Berglund","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4060","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/ajt.13917","article-title":"Patterns of end-stage renal disease caused by diabetes hypertension, and glomerulonephritis in live kidney donors","volume":"16","author":"Anjum","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-198512000-00015","article-title":"Pregnancy after donor nephrectomy","volume":"40","author":"Buszta","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4070","first-page":"3082","article-title":"Pregnancy following kidney donation","volume":"25","author":"Jones","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4075","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-199612270-00044","article-title":"Pregnancy after donor nephrectomy","volume":"62","author":"Wrenshall","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4080","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1600-6143.2008.02427.x","article-title":"Pregnancy and birth after kidney donation: the Norwegian experience","volume":"9","author":"Reisaeter","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.23876\/j.krcp.18.0050","article-title":"Maternal and fetal outcomes of pregnancies in kidney donors: a 30-year comparative analysis of matched non-donors in a single center","volume":"37","author":"Yoo","year":"2018","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4090","doi-asserted-by":"crossref","first-page":"e13453","DOI":"10.1111\/ctr.13453","article-title":"Risk of adverse maternal and fetal outcomes during pregnancy in living kidney donors: a matched cohort study","volume":"33","author":"Davis","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4095","first-page":"A3578","article-title":"A higher place on the waiting list for kidney transplantation after earlier donation: a matter of give and take","volume":"155","author":"Hoitsma","year":"2011","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/PTS.0000000000000610","article-title":"Living donor nephrectomy: is it as safe as it can be? Analysis of living donor deaths in the United States","volume":"15","author":"Keith","year":"2019","journal-title":"J Patient Saf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4105","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/TP.0000000000003082","article-title":"Comparison of medium-term outcomes of living kidney donors with longitudinal healthy control in the United Kingdom","volume":"104","author":"Krishnan","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/j.ajkd.2019.09.015","article-title":"Long-term mortality risks among living kidney donors in Korea","volume":"75","author":"Kim","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1432-2277.2012.01439.x","article-title":"Very long-term follow-up of living kidney donors","volume":"25","author":"Fournier","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/TP.0b013e318254757d","article-title":"Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims","volume":"94","author":"Lentine","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4125","unstructured":"UK Transplant Registry annual activity reports and organ specific reports.Available from: https:\/\/www.odt.nhs.uk\/statistics-and-reports\/annual-activity-report\/"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4130","unstructured":"The 36th Annual ANZDATA (Australia and New Zeland Dialysis and Transplant Registry) Report (2013). (last updated 31-Dec-2012). consultado 8 Jul 2019. Available from: https:\/\/www.anzdata.org.au\/"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4135","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1681\/ASN.V123589","article-title":"Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates","volume":"12","author":"Ojo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4140","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4150","series-title":"Registro de Di\u00e1lisis y Trasplante renal. Informe 2017. 2018 (\u00faltima actualizaci\u00f3n diciemrbe 2018) consultado 15 Jul","author":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","year":"2020"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ndt\/gfs512","article-title":"Progression in comorbidity before hemodialysis initiation is a valuable predictor of survival in incident patients","volume":"28","author":"Ng","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4160","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1111\/j.1600-6143.2006.01523.x","article-title":"Access to the kidney transplant wait list","volume":"6","author":"Kiberd","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4165","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/ajt.12332","article-title":"Influence of test technique on sensitization status of patients on the kidney transplant waiting list","volume":"13","author":"Gombos","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4170","series-title":"(Organizaci\u00f3n Nacional de Trasplantes) Memorias de actividad y donacion en trasplantes, a\u00f1o","author":"Spanish National Transplant Organization","year":"2019"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4175","first-page":"260","article-title":"The influence of donor age on function of renal allografts from live related donors","volume":"39","author":"Sumrani","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000658-200108000-00004","article-title":"2,500 living donor kidney transplants: a single-center experience","volume":"234","author":"Matas","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4185","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/S0041-1345(98)00958-0","article-title":"Impact of donor age on long-term graft survival in living donor kidney transplantation","volume":"30","author":"Kahematsu","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.tp.0000255583.34329.dd","article-title":"Living donor kidney transplantation: the effects of donor age and gender on short- and longterm outcomes","volume":"83","author":"Oien","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-0012.1994.tb00281.x","article-title":"Should elderly donors be accepted in liverelated renal transplant programs?","volume":"8","author":"Kumar","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00336387","article-title":"Living related kidney donors over 60 years old","volume":"9","author":"Lezaic","year":"1996","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4205","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ndt\/gfx036","article-title":"Barriers to living donor kidney transplantation in the United Kingdom: a national observational study","volume":"32","author":"Wu","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12882-016-0264-0","article-title":"Predicting patient survival after deceased donor kidney transplantation using flexible parametric modelling","volume":"17","author":"Li","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4215","first-page":"694","article-title":"Factors affecting graft and patient survival after live donor kidney transplantation in the UK","volume":"89","author":"Fuggle","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4220","series-title":"tissue and organ transplantation. consultado 2 Abr","author":"WHO Guiding Principles on human cell","year":"2018"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4225","series-title":"Recommendations on best practice. International Conference on Living Donation, Barcelona (Spain), 6-7 Nov 2014. consultado 2 Abr","author":"Living Donor Observatory (LIDOBS)","year":"2018"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4230","unstructured":"Ley de Trasplantes. https:\/\/www.boe.es\/eli\/es\/l\/1979\/10\/27\/30"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4235","unstructured":"Trasplante renal de donante vivo en Espa\u00f1a. An\u00e1lisis de Situaci\u00f3n y Hoja de Ruta, elaborado de forma conjunta por la Organizaci\u00f3n Nacional de Trasplantes (ONT), la Sociedad Espa\u00f1ola de Nefrolog\u00eda (SEN, a trav\u00e9s del Grupo de Trasplantes) y la Sociedad Espa\u00f1ola de Trasplantes (SET). (En Prensa)."},{"key":"10.1016\/j.nefroe.2022.07.001_bib4240","series-title":"Document developed by the Working Group on Living Donation under the European Union \u201cAction Plan on organ donation and transplantation (2009-2015): Strengthened Cooperation between Member States\u201d","author":"Toolbox Living Kidney Donation","year":"2016"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4245","unstructured":"ONT. Programa Marco de Calidad y Seguridad. Proceso de empaquetado y etiquetado. Available from: https:\/\/www.ont.es\/infesp\/Programa%20Marco%20de%20calidad%20y%20Seguridad\/3.%202.%20Proceso%20de%20empaquetado%20y%20etiquetado.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4250","unstructured":"ONT. Programa Marco de Calidad y Seguridad. Proceso de traslado de \u00f3rganos para trasplante sin equipo extractor. Available from: https:\/\/www.ont.es\/infesp\/Programa%20Marco%20de%20calidad%20y%20Seguridad\/4.%201.%20Proceso%20de%20traslado%20de%20%C3%B3rganos%20para%20trasplante%20sin%20equipo%20extractor.pdf"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.kint.2017.01.032","article-title":"Cold ischemia time up to 16 hours has little impact on living donor kidney transplant outcomes in the era of kidney paired donation","volume":"92","author":"Gill","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2022.07.001_bib4260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.15527","article-title":"The \u201coldest and coldest\u201d shipped living donor kidneys transplanted through kidney paired donation","volume":"20","author":"Nassiri","year":"2020","journal-title":"Am J Transplant"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251422000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251422000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:50:57Z","timestamp":1761853857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251422000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":852,"alternative-id":["S2013251422000797"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2022.07.001","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for living donor kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}]}}